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ABSTRACT
Enhancing Protein and Enzyme Stability Through Rationally
Engineered Site-Specific Immobilization
Utilizing Non-Canonical
Amino Acids
Jeffrey Chun Yu Wu
Department of Microbiology and Molecular Biology, BYU
Doctor of Philosophy

The demand for economical, efficient protein production, reuse, and recovery has never
been greater due to their versatility in a large variety of applications ranging from industrial
chemical manufacturing to pharmaceutical drug production. The applications for naturally and
artificially produced proteins include protein drugs and other pharmaceutical products, as
biocatalysts in environmentally friendly chemical manufacturing, as enzymes for food
processing purposes, and as an essential component in many biomedical devices. However,
protein production suffers from many challenges, which include the cost of production, protein
stability especially under harsh conditions, and recoverability and reusability of the proteins.
The combination of two developing technologies, cell-free protein synthesis systems (CFPS) and
unnatural amino acid incorporation, provides solutions to these protein production challenges.
This dissertation reports on the use of cell-free protein synthesis systems and unnatural
amino acid incorporation to develop new proteins and enzyme immobilization techniques that
significantly increase activity and stability while simplifying recoverability and reuse.

Keywords: Synthetic biology, biocatalysis, enzyme immobilization, cell-free synthetic biology,
green manufacturing, protein immobilization, click chemistry.
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1.

Introduction

1.1

Background
The demand for economical, efficient protein production, reuse, and recovery has never

been greater due to their versatility in a large variety of applications ranging from industrial
chemical manufacturing to pharmaceutical drug production (Clark, 2009). The applications for
naturally and artificially produced proteins include protein drugs and other pharmaceutical
products, as biocatalysts in environmentally friendly chemical manufacturing, as enzymes for
food processing purposes, and as an essential component in many biomedical devices (Alcalde et
al., 2006; Schmid et al., 2001). However, protein production suffers from many challenges,
which include the cost of production, protein stability especially under harsh conditions, and
recoverability and reusability of the proteins. The combination of two developing technologies,
cell-free protein synthesis systems (CFPS) and unnatural amino acid incorporation, provides
solutions to these protein production challenges.
Cell-free protein synthesis systems or in vitro protein expression systems enable
unparalleled access to the protein production environment when compared to in vivo systems
(Carlson et al., 2011). This open access allows for careful optimization and control of such
environmental conditions such as pH, salt concentrations, redox potential, energy sources,
mRNA, addition of catalysts and chaperones, and many others (Ahn et al., 2008b; Park et al.,
2011a; Park et al., 2009c; Purnick and Weiss, 2009). Cell metabolism is focused primarily on
survival and reproduction. The elimination of this evolutionary imperative enables the
manipulation of cell metabolic systems to focus entirely on the production of a target protein or
set of proteins (Ranjil et al., 2013). Such manipulation of the in vivo environment facilitates
production of proteins that may be difficult or impossible to produce in large quantities in vivo
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such as cytotoxic proteins or proteins containing unnatural amino acids or artificial moieties
(Kigawa et al., 2002; Ranjil et al., 2013).
Of the many unique proteins that the direct access of the cell-free system enables,
proteins incorporating non-canonical amino acids with useful functional groups are particularly
versatile for applications ranging from bioimaging, vaccines, drug production, and biocatalysis.
Non-canonical amino acids may include photoactivatable cross-linkers, fluorescent functional
groups; metal binding functional groups; and many other groups containing a large variety of
versatile and valuable qualities enabling the creation of new proteins and enzymes with never
before created traits.
Given the versatility of the synthetic biology cell-free protein production system and its
growing abilities to produce new and completely unique proteins that cannot be naturally
produced, this dissertation reports on research advancements made in the course of developing
the first truly covalent protein and enzyme immobilization technology that enables
immobilization at potentially any residue using bioorthogonal and biocompatible techniques.
Research advancements made while developing this technology include advancements in the
producing proteins with non-canonical amino acids, improved understanding of the effects of
non-canonical amino acid incorporation on protein activity and stability, and the major
improvements in protein and enzyme activity and stability when immobilized in a rationally
directed and site-specific manner. For the ease of the reader, a guide to the chapters is provided
below.
1.1

Guide to the Chapters
A significant proportion of this dissertation consists of adaptations from publications that

I personally led, developed, and authored. As described on a chapter by chapter basis, other
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researchers provided valuable and significant contributions to this work. These chapters are
summarized below.
Chapter 2: Transforming Synthetic Biology with Cell-free Systems.
This chapter is an adaptation from a review chapter from Synthetic Biology: Tools and
Applications published in June 2013. Although the review chapter was written in collaboration
with the Jewett Research Group at Northwestern, it has been edited to remove all sections written
by our collaborators and includes only sections written by me with valuable support from my
advisor, Bradley C. Bundy.
Chapter 3: Enhanced Protein Stability Through Minimally Invasive, Direct, Covalent, and Sitespecific Immobilization
This chapter is an adaptation from an article entitled “Enhanced Protein Stability Through
Minimally Invasive, Direct, Covalent, and Site-specific Immobilization” published in
Biotechnology Progress in January 2013. This chapter discusses the major stability benefits
from site-specifically and covalently immobilizing sfGFP onto a superparamagnetic bead
surface.
Chapter 4: Enhancing Candida antarctica Lipase B Activity, Stability, and Reusability Through
Rationally Directed, Site-specific Immobilization
This chapter discusses adaptations of the E. coli-based prokaryotic cell-free protein
synthesis system to produce the eukaryotic, industrially relevant enzyme Candida antarctica
Lipase B with non-canonical amino acids.
Chapter 5: Enhanced Enzyme Stability Through Site-Directed Covalent Immobilization
This chapter discusses the introduction of the first truly covalent, site-specific enzyme
immobilization technique that enables immobilization at potentially any residue throughout the
enzyme. The effects of enzyme stability predictions from previous molecular modeling studies
3

are compared with experimental data produced using our new technology. Significant
improvements in enzyme stability over traditional techniques are demonstrated under harsh,
denaturing conditions.
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2.

Transforming Synthetic Biology with Cell-Free Systems
This chapter is an adaptation from a review chapter titled “Transforming Synthetic

Biology with Cell-free Systems” in Synthetic Biology: Tools and Applications published in June
2013. Although the chapter was written by me with substantial assistance from my advisor in
collaboration with the Jewett Research Group of Northwestern University, it has been edited to
remove all sections written by our collaborators.
2.1

Introduction
Synthetic biology is a new approach for engineering biology by design. At its heart, this

emerging discipline seeks to make biology easier to engineer and to harness biology to serve
society. Already, this new paradigm for engineering biology is enabling a deeper understanding
of living systems and opening the way to sustainable and renewable energy production, costeffective and widely accessible programmable medicines, and new solutions for environmental
stewardship. While most synthetic biology efforts have focused on engineering living organisms,
the cell’s operating system and endogenous pathways pose an obstacle to synthetic biology
efforts. This is because the cell’s evolutionarily optimized agenda for growth and adaptation are
often at odds with the engineer’s objectives. Additionally, the complexity of living cells is still
beyond our comprehension, and serves as a disadvantage to using living cells to develop
synthetic biology applications. Cell-free systems circumvent these obstacles, and are emerging as
a powerful approach for harnessing and expanding the capabilities of natural biological systems.
Over the last several years there has been tremendous development and innovation in the
growing, yet still small, field of cell-free synthetic biology. This chapter focuses on recent
developments and current applications in this field. We begin by defining cell-free biology and
its advantages. We then highlight existing applications in cell-free synthetic biology from
5

proteins to metabolites (Figure 2-1). Finally, we consider some challenges and opportunities
necessary to propel the field forward.
2.2

Cell-free Biology
Cell-free biology is the activation of complex biological processes without using intact,

living cells. Bypassing cell walls, this approach opens up a whole new biological world, one
without the need or ability to preserve DNA heritage. Moreover, this approach enables one to
access and manipulate biology directly. In contrast to in vivo engineering efforts, this direct
relationship with biocatalytic enzymes provides the ability to focus metabolism on the
production of a single compound and removes physical barriers (allowing easy substrate
addition, product removal, and rapid sampling). Furthermore, avoiding competition between cell
growth (catalyst synthesis) and production (catalyst utilization) through the use of cell-free
systems provides efficiency benefits for how we use synthetic biology for synthetic chemistry. In
short, cell-free systems provide an unprecedented freedom of design to modify and control
biological systems.
Cell-free systems can be generated from crude extracts or purified components. Crude
extracts are prepared by lysing cells (typically harvested in the exponential growth phase) and
are cheaper, as well as simpler to produce than purified systems. While crude extract-based
systems are prominent in the field and have now been commercialized, purified systems also
have their merits (Zawada et al., 2011). Specifically, the fact that every component of a purified
system is well-characterized and can be tuned provides advantages for engineering design.
Furthermore, purified systems lack unwanted activities (such as proteases and nucleases) that
might be deleterious to crude extract systems. An example of a well-utilized purified system is
the PURE system for cell-free translation, pioneered by the Ueda group (Shimizu et al., 2001).

6

Figure 2-1: Applications of Cell-free Synthetic Biology (Ranjil et al., 2013).
Scale has long been considered a technological limitation of cell-free systems. Due to
recent advances in cost-effective high-level protein synthesis (Carlson et al., 2011), E. coli-based
cell-free protein synthesis systems have been successfully scaled-up to the manufacturing scale
(Zawada et al., 2011). Production rates, production yields, and product activity were maintained
over a volumetric expansion of 6 orders of magnitude (Voloshin and Swartz, 2005; Zawada et
al., 2011). This pioneering advance has transformed cell-free systems from a foundational benchtop tool into an enabling technology with promise for commercial scale applications.
2.3

Advantages of Cell-free Biology
Cell-free technologies simplify biological systems and remove unnecessary overheads for

engineering efforts. In this section, we highlight some of the many advantages gained by
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removing physical barriers and decoupling cellular catalysts from the genetic architecture of the
cell.
Direct Environment Control of an Open System
Cell-free biology enables direct access to and control of the biological environment. In
living cells, the organism must maintain an environment conducive to every biocatalytic
mechanism necessary for survival. In contrast, the cell-free environment can be directly
optimized for a user-defined objective. The indispensable microbiology workhorse of
polymerase chain reaction (PCR) is a simple but powerful cell-free synthetic biology example
where the DNA polymerase, template, primer, and salt concentrations are directly controlled and
optimized in a nuclease-free environment (Saiki et al., 1988). In another useful but simple cellfree example, RNA transcription can also be directly optimized while maintaining an RNasefree environment (Sousa and Mukherjee, 2003). In cell-free protein synthesis, the capability to
directly control variables such as ionic strength, pH, redox potential, hydrophobicity, and
enzyme and reactant concentrations has provided extraordinary advantages.
Direct Influence of Reaction Networks
Open cell-free biology enables the addition or removal of catalysts and/or reagents to
directly influence reaction networks. In one example, Zhang and coworkers have demonstrated
the optimized combination of 12 enzymes for 99.6% energy-efficient biohydrogenation of xylose
and cellobiose to xylitol (Wang et al., 2011). This example, along with others like it, showcases
the freedom of design for building metabolic networks from the ground up using cell-free
systems (Jewett et al., 2008; Zhang et al., 2007a; Zhang et al., 2011b). In another example, cellfree circuits can be built and controlled by the addition of enzymes to the nucleic-acid-based
circuits to control their rates of synthesis and degradation (Kim et al., 2006b). In the case of cell-
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free protein synthesis, the open environment enables simplified preparations of PCR products for
protein expression. Expression templates can be directly added and the concentration controlled
for optimization. In one example, linear expression templates (LETs) prepared using PCR have
been effectively used in cell-free translation systems by multiple research groups (Lesley et al.,
1991; Park et al., 2011a; Woodrow et al., 2006). LETs obviate the need for time-consuming
gene-cloning steps, accelerating process and product development pipelines. The ability to use
LETs in the cell-free system is particularly valuable when the goal is the production of a large
array of gene products, such as in genomic studies (Woodrow et al., 2006).
Direct Product Access
In cell-free systems, the lack of cell walls or membranes facilitates online product
monitoring, one-step purification and recovery of DNA, RNA, or protein (Ahn et al., 2008a;
Alimov et al., 2000). In the case of cell-free protein synthesis, several single-step purification
processes using affinity chromatography have been demonstrated (Alimov et al., 2000; Jewett
and Swartz, 2004b). These include strep- and his-tag purification and in situ product purification
using magnetic affinity beads (Kim et al., 2006d). In another illustrative model, Bujara et al.
coupled cell-free metabolic engineering to mass spectrometry analysis for direct profiling of ratelimiting steps to optimize multienzyme catalysis of dihydroxyacetone phosphate (DHAP) from
glucose (Bujara et al., 2010).
Focusing Biological Machinery on a Single User-Defined Objective
Without the need, or ability, to support ancillary processes required for adaptation and
growth, cell-free systems offer the ability to focus metabolism towards the exclusive objective of
the engineer, and not the cell. This affords efficiency advantages necessary for producing
complex biochemical products.
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Accelerating Design-Build-Test Cycles
Engineering biology today is a time- and money-intensive process. Therefore, one of the
key objectives of synthetic biology is to accelerate the design-build-test loops required for
engineering biology. Right now, in vivo approaches take, on average, 3-4 months to complete
this cycle (Dr. Alicia Jackson, DARPA ‘Living Foundries’ Industry Day 2011, personal
communication). Much of this time is taken to identify and modify potential genes, and assemble
and synthesize the potential pathways in living organisms. However, the design cycle limit of in
vivo synthetic biology projects could at best potentially scale (in the future) as the growth rate of
the organism and time for transformation. In cell-free systems, the design cycle is not limited by
how fast cells reproduce. Rather, it can be faster, potentially approaching the limit of
synthesizing the components (DNA, RNA, proteins). Ultimately, cell-free systems may therefore
speed up the design cycle for engineering by more than 10-fold relative to in vivo approaches,
and could be used as their own biomanufacturing platforms, or as feedback in the design of in
vivo platforms.
Decreased Effects of Toxicity
Due to cell death and hindered cell growth, in vivo production of both cytotoxic products
and products synthesized from cytotoxic substrates is a challenge. Unhindered by cell viability
constraints, cell-free systems address this challenge. Over the last decade, researchers have
demonstrated the use of cell-free systems to produce a growing number of cytotoxic products
(Katzen et al., 2005). These include proteins with cytotoxic amino acids (Kigawa et al., 2002;
Usón and Sheldrick, 1999), cytolethal disease toxins (Avenaud et al., 2004), cytotoxic proteins
(Smith et al., 2011), and others (Wuu and Swartz, 2008). In one exemplary approach, hepatitis
researchers studying a cytolethal distending toxin from Helicobacter hepaticus had been unable
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to produce sufficient levels of protein in vivo to observe its mechanism of action due to its high
cytotoxicity. Using a cell-free approach, researchers were able to produce sufficient quantities to
examine the toxin’s effect on the liver (Avenaud et al., 2004). In another illustrative case, cellfree translation of the cytotoxic A2 protein led to yields almost 1000 times higher than
previously reported with in vivo production (Smith et al., 2011).
Expanding the Chemistry of Life
The products of biological systems are governed by the chemistry of life, which is limited
to natural building blocks. Cell-free systems offer advantages for using synthetic biology for
nonstandard chemistry (Harris and Jewett, 2012). One of the most prominent examples is using
cell-free protein synthesis for site-specific incorporation of non-natural amino acids. In contrast
to in vivo systems, there are no transport limitations for getting non-natural amino acids into the
cell, and there is flexibility for reprogramming the genetic code because cellular viability need
not be maintained. By employing cell-free protein synthesis, the putatively transport-limited ppropargyloxyphenylalanine was incorporated site-specifically into proteins at significantly higher
production yields than in vivo systems (Bundy and Swartz, 2010). The high-yielding site-specific
incorporation of azidophenylalanine and the global replacement of methionine by an unnatural
analogue have also been demonstrated with cell-free systems (Goerke and Swartz, 2008; Patel
and Swartz, 2011).
2.4

Utilizing Cell-free Systems for Protein Production
In contrast to in vitro efforts in DNA and RNA that mainly center on building and

understanding nucleic acid circuitry, major in vitro efforts in proteins have been focused on
synthesis and evolution strategies. Indeed, a technological renaissance has reinvigorated cellfree protein synthesis (CFPS) technologies over the past decade (Carlson et al., 2011). This
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progress has realized protein yields exceeding grams of protein produced per liter reaction
volume, cost reductions of multiple orders of magnitude, and microscale to manufacturing scale
production. Here we discuss both bottom-up and top-down approaches to CFPS, along with
frontier applications enabled by recent advances.
Bottom-up Cell-free Protein Synthesis Systems
The bottom-up approach to CFPS centers on using purified components. Pioneered by
Ueda and colleagues, the most prevalent bottom-up system is the PURE system (Shimizu et al.,
2001; Shimizu et al., 2005). In the PURE system, cellular machinery necessary for translation is
independently overexpressed, purified, and combined in a test tube (Ohashi et al., 2010). An
advantage of the PURE system is that the researcher is afforded the greatest management of
every aspect of the protein synthesis process. Indeed, the ability to mix and match nearly any
component of translation has proven remarkably useful for efforts to fold proteins and to
incorporate non-natural amino acids (Harris and Jewett, 2012; Shimizu et al., 2005). The main
disadvantage to this system is its cost. The necessity of expressing, purifying, and adding each
component greatly increases the reagent cost and time required compared to top-down systems
(Hodgman and Jewett). A cost comparison of the CFPS systems discussed herein is provided as
Table 2-1.
Top-down Cell-free Protein Synthesis Systems
The top-down approach involves the modification and engineering of crude cell extract for
protein production. Although any organism can potentially provide a source of crude lysate, the
most frequently utilized crude extract systems are made from Escherichia coli, wheat germ,
rabbit reticulocytes, and insect cells (Carlson et al., 2011).
The E. coli-based CFPS systems are currently the most widely used due to lower labor
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requirements for cell growth and extract preparation, lower-cost energy sources, higher yields,
greater rate of protein synthesis, and commercial scalability (Swartz, 2006; Zawada et al., 2011).
Given the significant number of proteins previously expressed in this system and its high linear
scalability (from 15 μL to 100 liters), the E. coli-based CFPS currently demonstrates the greatest
versatility and economic efficiency (Table 2-1) (Carlson et al., 2011). However, this cell-free
system still faces post-translational modification challenges, although a new report has described
glycosylation in these systems for the first time(Guarino and DeLisa, 2012). Other bacteriabased cell-free systems have been developed, notably from thermophiles such as Thermus
thermophiles (Uzawa et al., 2002).
Eukaryote-based CFPS systems are mainly derived from wheat germ, rabbit reticulocytes, and
insect cells. Wheat germ extract-based cell-free systems provide the highest yields of the major
eukaryotic cell-free systems (Madin et al., 2000; Park et al., 2009c). Using a cell-free proteinproducing gel, one group reported yields as high as 5 mg/ml, approaching the highest yields
reported for E. coli-based cell-free synthesis, but at much lower volumes (Park et al., 2009c).
Unfortunately, wheat germ extract preparation is more costly and more labor-intensive than E.
coli-based systems. Rabbit reticulocyte-based cell-free systems require a highly technical and
difficult extract preparation method, but are used because of their ability to enable some posttranslational modifications (Hancock, 1995; Pelham and Jackson, 1976; Ryabova et al., 1989).
Low expression yields linked to the significant amount of ribonuclease M in the lysate, however,
limit their utility (Endo and Sawasaki, 2006b). Additionally, the collection of sufficient amounts
of reticulocytes requires harmful chemical treatments of rabbits (Ryabova et al., 1989).
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Table 2-1: Common Energy Sources and the Relative Cost of Cell-free Protein Production Using
Commercial Kits (Ranjil et al., 2013).
CFPS Type
Escherichia coli
Lysate

•
•
•
•
•
•
•

Wheat Germ
Lysate

•

Insect Cell Lysate •
Purified
Component

•

Rabbit
Reticulocyte Cell
Lysate

•

Commonly Used Energy
Sources
Phosphoenolpyruvate
(Jewett and Swartz,
2004a)
Pyruvate (Jewett and
Swartz, 2004a)
Acetyl kinase/acetyl
phosphate (Ryabova et al.,
1995)
Glucose (Calhoun and
Swartz, 2005)
Creatine kinase/creatine
phosphate (Park et al.,
2011a)
Creatine kinase/creatine
phosphate/glucose (Kim et
al., 2007)
Creatine kinase/creatine
phosphate/cAMP (Ma et
al., 2010)
Creatine kinase/creatine
phosphate (Madin et al.,
2000)
Creatine kinase/creatine
phosphate (Ezure et al.,
2006b)
Creatine kinase/creatine
phosphate (Ueda et al.,
2010)
Creatine kinase/creatine
phosphate (Hino et al.,
2008)

Extract Preparation
Time
1-2 days

Relative Cost (per
ng protein yield)*
~$0.70-$1**(Endo
and
Sawasaki,
2006a)

4-5 days

~$1.50-$3***
(Carlson et al.,
2011)
~$4-$9.25****

1-2 days
Extract not used, 32
individually purified
components.
4 days for rabbit
treatment, 1 day for
extract prep

~$11******
~$30-$100*****
(Endo
and
Sawasaki, 2006a)

* Cost assessed using maximum yields of respective commercial kits.
** Expressway Maxi Cell-free E. coli Expression System from Invitrogen, S30 T7 High-yield
Expression Kit from Promega,
*** Wheat Germ Extract Cell Free Protein Synthesis Kits from Genecopoeia,
**** TnT® T7 Insect Cell Extract Protein Expression System from Promega
***** TnT-coupled Reticulocyte Lysate System from Promega
****** PURExpress In vitro Protein Synthesis Kit from NEB.
Commonly produced from Spodoptera frugiperda cells, insect-based CFPS provide an
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effective combination of ample protein yield and post-translational modifications (Ezure et al.,
2006a). Commercial insect cell-based systems have reached yields of up to 50 μg/ml (Ezure et
al., 2006a). They also have been used successfully for several forms of post-translational
modifications including glycosylation, isoprenylation, acetylation, N-myristoylation, and others
(Suzuki et al., 2006, 2007; Tarui et al., 2001). Due to the cost of insect cell cultivation and
extract preparation, insect cell-based cell-free systems are more costly than E. coli-based or
wheat germ-based systems. While each of the CFPS systems developed to date has their merits
and trade-offs, we turn our attention to several case studies that highlight the advantages of
having direct access and control to the reaction conditions, as well as emerging applications
made possible by recent technical advances.
2.5

Advantages Achieved By Directly Influencing Reaction Conditions
As mentioned above, cell-free biology provides the ability to directly manipulate and

modulate reaction conditions. We now highlight several illustrative examples where ionic
strength, pH, redox potential, hydrophobicity, and translation components were tuned. The
overall ionic strength and the relative concentration of a specific ion can significantly impact the
structure and activity of many enzymes and proteins (Hu et al., 2011; Jaenicke, 1991; Sedov et
al., 2011; te Velthuis et al., 2010). For example, macromolecular protein structures such as viruslike particles have been shown to assemble at higher efficiencies as the ionic strength is
increased (Zlotnick et al., 2002). Viral RNA polymerases are commonly inhibited by high
concentrations of zinc (te Velthuis et al., 2010). Cell-free biology enables direct optimization of
the ionic strengths for both the performance of the enzyme machinery and the activity of the
product protein. By utilizing cell-free translation and assembly reactions, the highly efficient
translation and assembly of macromolecular virus capsids has been demonstrated (Bundy et al.,
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2008; Bundy and Swartz, 2011; Smith et al., 2011). Also, the cell-free assembly of the human
hepatitis B virus and human papillomavirus capsids were observed to be the highest at ionic
strengths that would be cytotoxic to most cells (Ceres and Zlotnick, 2002; Zlotnick et al., 2002).
Cell-free biotechnology also enables the ability to directly control the redox potential,
which is not possible in cells. In an exemplary illustration, Zawada et al. carried out a
combinatorial optimization of reaction conditions for both protein expression and folding
(Zawada et al., 2011). By modulating the redox potential and disulfide bond isomerase
concentrations, they achieved greater than 95% solubility for a protein containing multiple
disulfide bonds. This is in contrast to in vivo studies where correctly folding such complex
proteins is very difficult. Indeed, cell-free production of many active disulfide-bonded proteins
and disulfide-bonded macromolecular complexes has been achieved, including E. coli alkaline
phosphatase, human granulocyte-macrophage colony-stimulating factor, Candida antarctica
lipase B, human lysozyme, Gaussia princeps luciferase, and the Qβ virus-like particle which
contains up to 180 disulfide bonds (Bundy and Swartz, 2011; Ezure et al., 2007; Park et al.,
2009a; Zawada et al., 2011). Although a subtle point, the less-crowded environment of the cellfree reaction (relative to in vivo concentrations) helps provide for improved protein folding.
The open nature of cell-free translation also enables the use of several synthetic approaches
to increase solubility of highly insoluble proteins such as membrane proteins (Betton and Miot,
2008). In many instances, detergents have been used to alleviate protein solubility issues (Gilbert
G, 2007). In one example, detergents and chaperone proteins were successfully used in the cellfree system to produce an active form of an insoluble cancer-linked protein that had never been
produced in vivo (Pedersen et al., 2011). More recently, others have focused on the use of
nondetergent surfactants, amphipols, and fluorinated surfactants to increase solubility without
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damaging protein structural integrity (Park et al., 2011b). Other recent breakthroughs have
included insertion of insoluble proteins into synthetic liposomes with verified postinsertion
functionality (Um et al., 2006).
Recently, advances in protein-producing scaffold technology have produced synthetic
hydrogels capable of cell-free production yields approaching those of any solution-based cellfree systems (Park et al., 2009b; Park et al., 2009c; Um et al., 2006). Hydrogels are scaffolds
made up of linked networks of strongly hydrophilic polymers and mimic hydrophilic
physiological environments (Park et al., 2009b). These hydrogels have been reported to be
compatible with various cell-free systems, and capable of generating protein yields up to 5
mg/ml (Park et al., 2009c).
2.6

Applications
Improvements in productivity, scale, and complexity of recombinant protein synthesized

have rapidly expanded the utility, and now industrialization, of CFPS systems. In this section, we
highlight several emerging applications, focusing on protein microarrays, protein evolution, and
synthetic proteins.
Currently, the synthesis of proteins for functional analysis, structural genomics projects, or
the identification of novel characteristics is a multi-step task. These tasks involve gene/vector
construction, protein expression, and functional analysis of the expressed protein. Unfortunately,
this process is time-consuming and costly (both in terms of funds and human capital), since it is
primarily a serial process where only a single or a few proteins are produced simultaneously.
High-throughput production of proteins using CFPS systems is now addressing this challenge.
Valuable for studying the synthesis of many proteins simultaneously, protein microarrays are
being developed at a rapid pace for improved large- scale protein expression and purification
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(Chandra and Srivastava, 2010). The basic principle of protein microarrays is that DNA
encoding a protein target of interest is printed onto a glass slide in a physically isolated location,
then CFPS synthesizes the target of interest (Ramachandran et al., 2004). To improve protein
isolation and stability, proteins are commonly engineered to include epitope tags (e.g. C-terminal
glutathione S-transferase tags) which bind the protein products to antibodies immobilized on the
slides(Ramachandran et al., 2004). In one exemplary report, parallel large-scale expression of
more than 13,000 human genes using a wheat germ extract has been achieved (Goshima et al.,
2008). Because the cell-free approach obviates the need to synthesize, purify, and immobilize
proteins separately, it allows for proteins with novel characteristics to be quickly generated and
analyzed. Further efforts to integrate gene synthesis on chips for protein analysis promise even
greater capability.
CFPS offers a rich and versatile platform for protein engineering. Specifically, the cell-free
system enables direct control of the environment to efficiently drive protein evolution to contain
the desired traits (Zahnd et al., 2007). Two major protein evolution strategies are in vitro
compartmentalization and ribosome display. In vitro compartmentalization (IVC) involves the
generation of an emulsion to create cell-like compartments (Zhu and Power, 2008). Ideally, each
compartment contains a single gene and all reaction components necessary for protein
transcription/translation. These separate compartments trap all gene products within an
individual compartment, preventing cross-contamination. The reaction components may either
be present all at once or added in several phases (Sepp and Choo, 2005). The formation of
compartments down to the femtoliter scale has made IVC by emulsion particularly attractive for
high-throughput protein evolution (Figure 2-2) (Zhu and Power, 2008). In contrast, the low-tech
physical method of IVC by microtiter plate has high reagent costs and the screening of one
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million genes could cost over $2.4 million (Fallah-Araghi et al., 2012). The implementation of
new ultrahigh-throughput microfluidic systems have dramatically reduced these costs (Agresti et
al., 2010). In one such system, the use of picoliter- sized droplets, low polydispersity emulsions,
and effective fluorescence sorting allowed the screening of one million genes in less than an hour
at a cost of less than $31 (Fallah-Araghi et al., 2012).
As a complement to IVC, ribosome display provides a simple mechanism for evolution of
proteins that will bind to a specific ligand (Wada et al., 2008; Yan and Xu, 2006). The ribosome
display process begins with a DNA sequence or library of sequences containing a spacer
sequence lacking a stop codon. Due to the spacer sequence, the ribosome remains bound to the
mRNA_protein complex post-translation and the nascent polypeptide is able to successfully fold
(Zahnd et al., 2007). The mRNA_ protein_ribosome complex can then be exposed to a surfaceimmobilized ligand for binding. Weak-binding complexes are washed away, leaving only highaffinity complexes. The mRNA of the highest affinity complexes are recovered, reverse
transcribed, PCR amplified, and then collected for future selection rounds (Yan and Xu, 2006).
In one example, ribosome display enabled the rapid selection of a designed ankyrin repeat
protein which binds the cancer-relevant epidermal growth factor 2 (Her2) at high selectivity and
nanomolar affinity (Zahnd et al., 2006).
Beyond protein microarrays and protein evolution, the synthesis of synthetic proteins is
another frontier application of CFPS. While Hecht and coworkers have elegantly shown the
ability to synthesize de novo proteins with unique functionality from combinatorial libraries, we
focus our discussion here on efforts to expand the chemistry of life by the introduction of
unnatural amino acids (Hecht et al., 2004). Efforts to use CFPS for unnatural amino acid
incorporation are beginning to grow. This is because of recent advances enabling cost- effective,
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high-level CFPS systems, and advantages over in vivo approaches. Namely, there are no
transport issues for unnatural amino acids, and there is greater flexibility for reprogramming the
translation system (Ohta et al., 2008).
The incorporation of unnatural amino acids to create novel proteins has been performed by
globally replacing a natural amino acid with an unnatural analogue, or by site-specifically
incorporating the unnatural amino acid while maintaining the natural amino acid cannon. The
global replacement method can be performed in the cell-free system by simply not adding an
amino acid such as methionine, and adding an unnatural amino analogue in its place. In a recent
report, methionine was globally replaced with azidohomoalanine to enable the efficient
attachment of proteins to virus-like particles for the development of a B-cell lymphoma vaccine
(Patel and Swartz, 2011). While simple in implementation, the global replacement method is
more likely to adversely affect protein function due to the loss of methionine from the amino
acid canon (Wang et al., 2006).
A number of site-specific incorporation methods have been developed. However, one of the
highest yielding and transferable methods involves utilizing an orthogonal tRNA/tRNA
synthetase pair specific to the amber stop codon, as developed by Schultz and coworkers (Xie
and Schultz, 2006).
The expression or addition of the tRNA/tRNA synthetase pair is relatively straightforward
in both in vivo and cell-free systems. However, due to the insoluble nature of some unnatural
amino acids and transport limitations of the unnatural amino acid into the cell, the efficient
incorporation of some unnatural amino acids in vivo can be challenging (Bundy and Swartz,
2010). Because of the direct access provided by cell-free systems, these limitations can be
overcome. By optimizing the tRNA/tRNA synthetase pair and using a continuous exchange cell-
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free system with linear templates, Ozawa et al. recently produced protein yields of over 2 mg/ml
for a protein with a single unnatural amino acid mutation (Ozawa et al., 2012). For site-specific
incorporation, the presence of release factor 1 (RF1) in cell-free extracts can compete with the
exogenous tRNA for the amber stop codon (Johnson et al., 2011). A significant improvement in
site-specific multisite incorporation of unnatural amino acid protein yields has been made by
producing an RF1 knockout strain of E. coli. With this strain, protein yields reached 57 μg/ml for
a protein with one unnatural amino acid site mutation, and 68 μg/ml for a protein with three site
mutations (Johnson et al., 2011). Although not attempted, the use of this strain in a cell- free
system could further improve the production of proteins containing unnatural amino acids.
Small Molecule Metabolites
Similar to CFPS, cell-free metabolic engineering for overproducing small molecule
metabolites occurs via either a bottom-up or top-down approach. Since the original discovery
that cell extracts could convert sugar into ethanol, there have been relatively few top-down
examples of metabolic engineering (Buchner, 1897). Efforts primarily by the Swartz and Panke
laboratories have developed the field; the former for activating energy pathways for fueling cellfree protein synthesis reactions (Swartz, 2012), and the latter for making desired small molecule
metabolites. In one example of this approach, the Panke group constructed an enzyme catalytic
system by fine-tuning a catalytic pathway with information from real-time analysis of
concentrations of the pathway intermediates (Bujara et al., 2010).
In contrast to extract-based systems, the bottom-up approach exploits the organization of
synthetic enzymatic pathways from purified components, sometimes to facilitate a process or
reaction that does not occur in nature (Khalil and Collins, 2010; Zhang et al., 2007b). In one
instance, a 13-step synthetic enzymatic pathway using starch and water produced hydrogen at
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yields far higher than the theoretical yields of biological hydrogen fermentations (illustrated in
Figure 2-3) (Zhang et al., 2007a).

Figure 2-2: In vitro compartmentalization by emulsion for protein evolution. 1-2. Cell-free
transcription/translation machinery and mineral oil form water in oil emulsions. 3. In each
emulsion, a single gene is transcribed and translated. 4. Protein-gene linkage may be performed
prior to selection. 5. Proteins are selected based on binding, catalytic, or regulatory capability.
6. Alternately, proteins may be selected through a fluorescence-assisted droplet sorting system
(FADS). 7. The genes for selected proteins undergo a new cycle of IVC. (Ranjil et al., 2013).
Indeed, because carbon flux is not directed towards cell growth, cell-free systems can
achieve higher theoretical yields than natural biological processes found in living organisms
(Swartz, 2012). Unfortunately, the high cost of purifying stable, standalone enzymes, and
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cofactor regeneration costs, currently limit synthetic enzymatic pathways to laboratory scale
research.
Cost Reduction
Cell-free biology offers remarkable opportunities for engineering biology. However, until
commercial products (e.g. proteins and metabolites) are made using cell-free systems, these
systems will mainly serve as test-beds for understanding biology and accelerating the design of
synthetic programs. To enable commercial applications, costs must continue to be reduced.
Cells have evolved many pathways to reliably produce energy from inexpensive raw
materials. In contrast, more expensive energy sources are typically used in cell-free systems. An
overarching goal for cell-free biology is to develop strategies for using the same energy substrate
molecules and waste feedstreams that are used to fuel in vivo synthetic biology efforts. Bottomup approaches will benefit from more efficient methods for rapid and cost-effective protein
production and purification, while more efficient and cost- effective extract preparation methods
are desired for top-down cell-free systems. With the E. coli-based cell-free protein synthesis
system, engineering the extract preparation method decreased the extract preparation time and
reagent cost by over 50%, and similar advances are expected to improve other top-down cell-free
systems (Kim et al., 2006c; Liu et al., 2005; Shrestha et al., 2014). Further advances will likely
couple high-throughput screens to characterize and assess the functions of proteins found in the
extract. In one illustrative example, Swartz and colleagues recently surveyed endogenous
proteins in E. coli for their influence on CFPS. Using this information, they were able to improve
CFPS yields up to 84 g/L in an 8-hour batch reaction (Woodrow et al., 2006).
Scale
With the exquisite control the open cell-free system enables, researchers have
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demonstrated the scalability of the cell extract-based cell-free protein synthesis reaction from the
microliter level to the 100-liter scale (Zawada et al., 2011). In addition to analogous product
protein yields, the production rates at the μL, mL, and L scale were virtually identical (Zawada et
al., 2011). Although scalability over six orders of magnitude to the 100 L scale has been
demonstrated, increasing to the 1000 L or even 10,000 L scale would enhance the attractiveness
of cell-free biology for commercial applications. Moreover, the development of a scalable
eukaryotic system is needed.
Development of Complex Biocatalytic Networks
The cell-free system provides an environment where the expression rate of multiple
products can be controlled in parallel to assess the impact of coproduction on an individual
product’s activity. This is particularly important when assembling complex macromolecular
assemblies such as the ribosome or virus-like particles. As recently demonstrated, small changes
in expression levels of one protein of multiprotein macromolecular complex can significantly
impact the efficiency and activity of the assembled macromolecular complex (Smith et al.,
2011). In addition, researchers have noted the engineering advantages of employing in vitro
enzyme-catalyzed biochemical reaction cascades to produce the desired natural product
(Santacoloma et al., 2010). The easily controlled and engineered open cell-free environment will
be exploited for optimizing multienzyme synthesis and activity for next-generation biocatalysts.
Efforts such as those by Forster and colleagues could provide directions (Du et al., 2009; Du et
al., 2012).
Purification and Localization of Multienzyme Ensembles
To produce a desired product from an inexpensive feedstock, multiple biocatalytic steps
are often necessary. A key challenge, therefore, for bottom-up cell-free systems is cost-effective
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purification of multienzyme ensembles. Offering one possible solution, a recent report from
Wang et al. leverages advanced genome engineering for simultaneous modification of catalysts
to be used in copurification strategies (Wang et al., 2012). This type of strategy, once further
developed, could lead to commercially relevant in vitro catalytic systems. Beyond strategies for
simultaneously modifying and copurifying large protein complexes and pathways, localization
may also be important. Nature has evolved highly efficient mechanisms to facilitate the transfer

Figure 2-3: A cell-free synthetic enzymatic pathway for converting starch and water into hydrogen
and carbon dioxide: This artificial pathway has been reported to produce hydrogen at yields
greater than the theoretical limits for industrial anaerobic fermentations (12 H2 per glucose
compared to4 H2 per glucose)(Zhang et al., 2007a). Molecular graphics images were produced
using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and
Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081).
(Ranjil et al., 2013).
of reactants through complex enzymatic pathways. For the production of secondary metabolites,
for example, type I polyketide synthetases actively transfer the reactant through a number of
catalytic domains that are locally constrained as part of the same protein. Biomimetic
engineering, the ability to control the proximity of multiple enzymes, could facilitate the rapid
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transfer of reactants through the correct sequence of biocatalytic events. Innovations in the
rapidly growing enzyme immobilization field could help facilitate the development of such
biomimetic multienzyme ensembles(Sheldon, 2007).
2.7

Conclusion
Cell-free synthetic biology is a powerful tool for understanding and expanding the basic

biology of living systems. Recent advances in nucleic acid circuitry, protein synthesis, and small
molecule production, amongst others, have heralded a new age of in vitro bioengineering. The
general simplicity and flexibility of in vitro systems serves as an excellent complement to in vivo
studies, and enables a more complete understanding of the inner workings of a cell. Cell-free
synthetic biology has versatile applications in protein synthesis and evolution, as well as the
development of nucleic acid circuits, nanomachines, and therapeutics.
Although cell-free systems have been used for over 50 years, more work is needed before
they can be used as commercial platforms for therapeutic and metabolite production. However,
recent advances have demonstrated commercial-scale protein synthesis with crude extract cellfree systems. In addition, continued engineering has rapidly driven down the cost and simplified
the preparation of many cell-free systems. With the remarkable progress made over the last 10
years, it is but a matter of time before several of the significant challenges facing the field evolve
into transformative synthetic biology opportunities.
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3.
Enhanced Protein Stability Through Minimally Invasive, Direct, Covalent, and Sitespecific Immobilization
This chapter is an adaptation from the January 2013 Biotechnology Progress article
entitled “Enhanced Protein Stability Through Minimally Invasive, Direct, Covalent, and Sitespecific Immobilization.” This research project was led by me in conjunction with a fellow
graduate student, Mark Smith, with the help of an undergraduate researcher, Christopher Werner.
3.1

Introduction
Proteins represent a $100+ billion USD industry with rapid annual growth (Sarrouh, 2012).

The utilization of proteins for bioprocessing, sensing, and medical treatment is widespread over a
number of industries including agricultural, textile, pharmaceutical, energy, and chemical
processing (Ragauskas et al., 2006; Schoemaker et al., 2003). Proteins have a number of
advantages over nonbiological chemicals and chemical processes due to: (1) superior chemo-,
regio-, and stereo specificity of enzymes (Bornscheuer, 2003; Grunwald, 2010; Patel, 2001;
Schoemaker et al., 2003); (2) green sustainability (renewable, biodegradable, nontoxic, milder
reaction conditions, less energy consumption) (Alcalde et al., 2006; Ragauskas et al., 2006;
Schmid et al., 2001; Schoemaker et al., 2003); and (3) optimization through protein engineering
(Vick and Schmidt‐ Dannert, 2011). However, difficulties in recovery, reuse, and long-term
stability limit the far-reaching industrial potential of proteins (Sheldon, 2007). Protein
immobilization is a potential solution as it simplifies protein recovery and reuse, and reportedly
increases protein stability in many cases (Adamczak and Krishna, 2004; Alcalde et al., 2006;
Bornscheuer, 2003). This work is focused on improving protein immobilization and we
introduce the Protein Residue-Explicit Covalent Immobilization for Stability Enhancement or
PRECISE system that enables the targeted immobilization of proteins to enhance protein stability
and durability.
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The most robust immobilization techniques for protein-surface bioconjugation are covalent
(Dyal et al., 2003; Wang et al., 2009a). However, precisely controlling which location on the
protein covalently binds to a surface is complicated by the naturally limited pool of only 20
amino acid building blocks. Covalently targeting a given amino acid which appears in multiple
locations in a protein commonly results in undesirable attachment orientations and loss of
activity and stability (Ladavière et al., 1998; Rusmini et al., 2007; Stephanopoulos and Francis,
2011).
A number of site-specific yet noncovalent approaches have demonstrated superior activity
using recognition pairs such as 6His/Ni,20 biotin/streptavidin (Yu et al., 2012), more generally
oligonucleotide/protein (Niemeyer, 2002). However, long-term stability and reusability are
compromised due to protein leaching that is further exacerbated under industrially relevant
conditions (Rusmini et al., 2007). In addition, such systems commonly require the fusion of large
tags which can negatively affect protein structure and function especially if inserted at locations
other than the terminus (Carson et al., 2007; Rusmini et al., 2007).
Increasingly, research efforts have focused on developing both a covalent and site-specific
immobilization technique. Specific targeting of the C and N termini for conjugation to peptide
tags has been successfully reported with tags such as transglutaminase (Tanaka et al., 2007) and
phosphatase (Gauchet et al., 2006), yet remains insufficient in cases where the termini are critical
to protein folding and/or function. To target residues within the protein, complete elimination of
all similar residues and chemical moieties except at the desired conjugation site can enable sitespecific covalent linkage (Ladavière et al., 1998). However, mutagenesis of this magnitude is
typically destabilizing. Alternatively, unnatural amino acids (uAAs) provide unique functional
groups which can react with a number of bioorthogonal and highly efficient reaction chemistries
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such as click chemistry, the Staudinger reduction, and Diels–Alder reaction-like cycloadditions
(Boyce and Bertozzi, 2011; Rusmini et al., 2007; Stephanopoulos and Francis, 2011). Global
replacement of a natural amino acid with an uAA analogue achieved by omission of the natural
amino acid during protein synthesis is commonly performed, although, site-specific
immobilization is still complicated by the incorporation of the unnatural amino acid at many
locations (Patel and Swartz, 2011; Strable et al., 2008).
The PRECISE system overcomes the reported issues of nonspecific and noncovalent
immobilization by building upon a developed technology that site-specifically incorporates a
single uAA at a single explicitly predetermined residue (Patel and Swartz, 2011; Wang et al.,
2001a; Young et al., 2010). This technology was initially developed as an in vivo Escherichia
coli-based system that uses orthogonal tRNA and aminoacyl-tRNA synthetase from
Methanocaldococcus jannaschii to incorporate the uAA only in the location encoded by the
amber stop codon (UAG) on the mRNA (Wang et al., 2001a; Xie and Schultz, 2006). Using this
method, over 70 uAA have been incorporated with generally high selectivity (Liu and Schultz,
2010; Wang et al., 2002). Two particularly attractive unnatural amino acids are ppropargyloxyphenylalanine (pPa) and p-azidophenylalanine (pAz) which can be used with the
highly selective, efficient, and biocompatible copper(I)-catalyzed azide-alkyne [3 + 2]
cycloaddition click reaction. Because of the photoinstability of pAz, this work focuses on the
incorporation of pPa to enable direct click chemistry to the surface.
Using the in vivo site-specific insertion technique, Kim et al. targeted a predetermined
residue location in the protein DrrA and clicked an alkyne-biotin with site-specifically
incorporated pAz (Seo et al., 2011). The biotin-linked protein was then surface-immobilized by
the noncovalent neutravidin-biotin interaction. Compared to randomly oriented immobilized
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DrrA, the orientation-specifically immobilized DrrA exhibited higher activity of DrrA(Seo et al.,
2011). Although Kim et al. demonstrated the capability of residue-explicit targeting, the
noncovalent link limits the immobilization's robustness.
The PRECISE system uses site-specific uAA and direct covalent immobilization,
eliminating the need for a noncovalent linker. In addition, the photostable pPa is incorporated
using an E. coli-based cell-free protein synthesis (CFPS) approach that eliminates membranetransport limitations and has resulted in up to a 27-fold increase in protein production yields for
proteins containing pPa (Bundy and Swartz, 2010). Other advantages of CFPS include direct
access and optimization of the synthesis environment, simplified purification, and highthroughput automation potential (Bundy and Swartz, 2011; Kim et al., 2011; Shrestha et al.,
2012).
The site-specific covalent surface immobilization of proteins presented herein provides a
unique balance of stable protein binding and orientation control without the need of noncovalent
linkers. While the technology for the site-specific incorporation of pPa using cell-free protein
synthesis has been previously reported (Bundy and Swartz, 2010), here we report the application
of this technology for site-specific immobilization of proteins onto nonprotein surfaces such as
superparamagnetic beads. Our results also indicate extended longevity and stability of active
bound proteins under biologically unfavorable conditions with potential implications for
industrial biocatalysis, protein microarrays technologies and other protein based diagnostic
applications.
3.2

Materials and Methods

3.2.1

Extract preparation
E. coli extract was prepared using a BL21 Star™ (DE3) E. coli strain purchased from
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Invitrogen (Carlsbad, CA) harboring the pEVOL-pPrF plasmid, a kind gift from Peter Schulz,
(Scripps Research Institute). The resulting E. coli strain produces the Methanocaldococcus
jannaschii aminoacyl-tRNA synthetase/tRNA pair capable of recognizing and inserting pPa at
the amber stop codon AUG.30 Cell extract was prepared as previously reported (Bundy and
Swartz, 2010; Bundy and Swartz, 2011) with the following modifications. The strain was
fermented in 1 L batches of 2xYT media buffered with 100 mM MOPS at 37°C and shaken in a
2.5 L Tunair baffled shake flask (IBI Scientific, Peosta, IA) at 280 rpm. Cells were lysed through
triple pass homogenization using an Avestin Emulsiflex B-15 cell disruptor (Ottawa, Canada) at
21,000 psi. Subsequently, the remaining cell extract was flash-frozen and stored at −80°C until
used.
3.2.2

Cell-free protein synthesis
Protein synthesis of T216pPa sfGFP (pPaGFP) was carried out in vitro using the PANOx-

SP system as previously described with the following minor modifications (Bundy and Swartz,
2010). Plasmids used were either pY71-sfGFP-Strep or pY71-T216Amb-sfGFP-Strep. Unless
specified, all reactions contained 2 mM pPa. BL21 Star™ (DE3) E. coli extract was added at
25% v/v, without additional T7 RNA polymerase. Reactions contained 7 μg mL−1
Methanocaldococcus jannaschii aminoacyl-tRNA synthetase affinity purified according to a
previously reported procedure(Goerke and Swartz, 2009). Reactions were performed at 30°C for
8 h or overnight.
3.2.3

Protein yield assays
Total and soluble protein yield calculations were performed using liquid scintillation

counting as discussed previously (Bundy et al., 2008; Smith et al., 2011). An analysis of fulllength protein yields was performed by first running sodium dodecylsulfate polyacrylamide gel
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electrophoresis on the supernatant of the CFPS reaction mixtures after centrifugation at 13,000g
for 15 min, and on strep-column purified protein as per the manufacturer's specifications (Life
Technologies, Carlsbad, CA). Autoradiograms were prepared on Kodak MR Autoradiography
Films (Rochester, NY) and densitometry calculations were performed using ImageJ software.43
3.2.4

Fluorescence activity assay
Fluorescence assays were performed using a Synergy MX (Biotek Instruments, Winooski,

VT) at 485/510 nm excitation/emission and sensitivity of 100 in 60 or 125 μL of PBS buffer per
well of a black-bottom 96-well plate.
3.2.5

Dynabead preparation
The superparamagnetic M-270 Dynabeads decorated with terminal amines were reacted

with azide-containing ligands, using a procedure adapted from Punna et al (Punna et al., 2005).
First, 4-nitrophenyl 5-azidopentanoate was synthesized through the addition of 5-azidopentanoic
acid (3.5 mmol) and p-nitrophenol (3.7 mmol) to a solution with 1-(3-dimethylaminopropyl)-3ethylcarbodiimide hydrochloride (3.7 mmol) in CH2Cl2 at room temperature overnight. The 4nitrophenyl 5-azidopentanoate was then concentrated and purified using silica gel column
chromatography.
After purification, the 4-nitrophenyl 5-azidopentanoate was dissolved in DMF and added to
a tube containing 2 mL of Dynabeads (2 × 109 beads per mL) in 5% MES buffer and stirred
gently at room temperature for 2 days. Measurement of the released p-nitrophenol absorbance at

32

Figure 3-1: Preparation of Azide-functional Surface (Smith et al., 2013).
412 nm was then performed and compared to a p-nitrophenol standard curve. A negative control
reaction containing no beads (no amines) was performed and no change in 412 nm absorbance
was observed suggesting no autohydrolysis of the 4-nitrophenyl 5-azidopentanoate. Beads were
vigorously washed 10 times with PBS buffer to remove excess and non-specifically adsorbed
azide ligand.
3.2.6

Click reaction (copper-catalyzed azide-alkyne cycloaddition)
The aqueous click reaction conditions were performed with either 1 mM CuSO4 and 5 mM

sodium ascorbate or 1 mM tetrakis(acetonitrile)copper(I) hexafluorophosphate (Cu(I)Tet) for
CuSO4 or Cu(I)Tet catalyzed reactions, respectively. Click reactions with Alexa Fluor® 555
alkyne (AF555) (Invitrogen, Carlsbad, CA) were performed exclusively with Cu(I)Tet with 0.2–
20 nmol of AF555 in 30–50 μL reaction volumes. The reaction volume for click reactions with
pPaGFP was 100 μL with 0.5 nmol pPaGFP and 5 nmol azide-functional groups in the reaction.
Reagents were prepared aerobically in microcentrifuge tubes with all components save the
catalyst and sodium ascorbate. Tubes were then transferred to an anaerobic glove box
atmosphere containing <0.0 ppm oxygen and allowed to degas for a minimum of 45 min. After
degassing, catalyst and, if required, sodium ascorbate was added. The closed tubes were then
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rotated end-over-end for 8–14 h in darkness. Reactions were terminated by removal of the tubes
from the anaerobic glove box and exposure to atmospheric oxygen.
3.2.7

Purification of click-immobilized pPaGFP
To purify the superparamagnetic beads from the click reaction solution, a DynaMag Spin

Magnet (Invitrogen, Carlsbad, CA) was used as follows. The microcentrifuge tubes containing
the click reaction were placed on the DynaMag Spin Magnet for 8 min, after which the
supernatant was removed. The tubes were then removed from the magnet, 100 μL PBS-Tween
buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 0.05% v/v Tween20)
was added to the samples, the samples were thoroughly vortexed, and the new suspensions were
incubated for 8 min at room temperature. Samples were returned to the DynaMag Spin Magnet
and the cycle was repeated two times. After the final removal of the supernatant, the sample was
resuspended in 100 μL PBS.
3.2.8

Freeze thaw
pPaGFP was immobilized on azide-functional Dynabeads using both CuSO4 and Cu(I)Tet

and purified as described above. In a single black 96-well plate (Plate A), both pPaGFP
immobilized on beads and free pPaGFP was aliquoted into different wells to a final volume of 60
μL in PBS buffer. In a separate black 96-well plate (Plate B), free pPaGFP was aliquoted into
different wells to a final volume of 60 μL in PBS buffer. Plate A was subjected to four freezethaw cycles by incubating it at −80°C for 20 min and then incubating it at room temperature for
20 min. Between each freeze-thaw cycle fluorescence measurements of the pPaGFP were taken
with the Synergy MX microplate reader as described above. Concurrently, Plate B was incubated
at 4°C and fluorescence measurements of the pPaGFP were also taken every 40 min.
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3.2.9

Urea/heat incubation
pPaGFP were immobilized on azide-functional Dynabeads using both CuSO4 and Cu(I)Tet

and purified as described above. In a single black 96-well plate (Plate C), both pPaGFP
immobilized on beads and free pPaGFP were aliquoted into different wells to a final volume of
50 μL in PBS buffer. To all wells containing pPaGFP immobilized on beads and to half of the
wells containing free pPaGFP was added 75 μL of 10 M urea, bringing the final urea
concentration to 6 M. To the remaining wells of free pPaGFP was added 75 μL of deionized
sterile water in place of urea. In a separate black 96-well plate (Plate D), free pPaGFP was
aliquoted into different wells to a final volume of 50 μL with PBS buffer following which 75 μL
of deionized sterile H2O was added.
Immediately after adding urea or water, Plate C was placed in the Synergy MS microplate
reader with the sample chamber temperature maintained at 50°C and assayed for fluorescence
activity every minute for 30 min. The plate was removed from the plate reader and cooled to 4°C
and assayed for fluorescence activity after 1.5 and 12 h. Place D was treated in a similar manner
with the exception of the microplate reader's sample chamber temperature being maintained at
room temperature.
3.3 Results and Discussion
The protein residue-explicit covalent immobilization for stability enhancement or
PRECISE system introduced herein allowed for retention of protein activity and increased the
stability and durability of the proteins. Azide-functional superparamagnetic beads were prepared
as the attachment surface and tested using small alkyne-functional fluorophores. Then, GFP
containing an unnatural amino acid (uAA) was synthesized, purified, and successfully
immobilized to the beads with the PRECISE system as illustrated in Figure 3-1. Immobilized
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GFP maintained a significant fluorescence activity and exhibited increased stability against
freeze-thaw cycles, urea and elevated temperature compared to unbound GFP, as will be
described in detail below.
3.3.1

Preparation of Azide-functional Surface
Superparamagnetic beads were selected as the immobilization surface for simplicity in

purification, recovery, and reuse. Furthermore, they provide a macro, inorganic surface for
conjugation. Amine-decorated superparamagnetic beads (Dynabeads® M-270, Invitrogen) were
modified with terminal azide groups as shown in Figure 3-2. To make the beads viable reagents
in the click reaction, the amine-coated beads were reacted with 4-nitrophenyl 5-azidopentanoate
and the release of p-nitrophenol was measured by absorbance to determine extent of reaction,
which resulted in azide-functionalization of 95% of the amine groups available as per the
manufacturer's specifications (Invitrogen).

Figure 3-2: The PRECISE System (Smith et al., 2013).
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3.3.2

Cell-free Protein Synthesis
Superfolder green fluorescent protein (sfGFP) was rationally engineered to incorporate an

uAA at T216 and to contain a C-terminal purification tag (Bundy and Swartz, 2010). The site
T216 was chosen for substitution by identifying a surface-accessible protruding loop near an end
of the cylindrical protein's crystal structure. The C-terminal Strep-tag provided means of
purifying full-length protein from truncated product, which occurs when the uAA is not
incorporated and results in early termination of the protein (Figure 3-2).

By carefully choosing the location of mutagenesis and avoiding alterations to the main structural
or active portions of the protein, the potential for improper folding or activity loss is minimized.
Indeed, the activity of purified uAA-containing sfGFP did not drop compared to the activity of
unmodified sfGFP (Bundy and Swartz, 2010).
The PRECISE system utilizes the open access afforded by CFPS to optimize
concentrations of the Methanocaldococcus jannaschii aminoacyl-tRNA synthetase, which works
together with its tRNA pair to incorporate the uAA pPa at the Amber stop codon. As displayed in
Figure 3-3 pPa was successfully incorporated ∼40% of the time when pPa was present in the

CFPS reaction. When pPa was absent, the protein was truncated at the amber stop codon with no
detectable incorporation of pPa (Figure 3-3, Lane 3), which is consistent with previously
reported works (Hohsaka et al., 2001; Saraogi et al., 2011).
The CFPS production approach has specific advantages over in vivo protein production
such energy focused toward expression of the product protein(s), simplified product purification,
and elimination of transport-limiting cell-walls (Bundy and Swartz, 2011). In addition, CFPS
enables direct access to the open synthesis environment and enables facile optimization and
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maximization in the concentration of synthetase, uAAs, and other cofactors essential for protein
synthesis.

Figure 3-1: SDS-PAGE and Autoradiogram of pPaGFP. The lanes are laid out from left to right
as follows: (1) pPaGFP post-Strep-tag purification; (2) synthesized pPaGFP prior to purification;
(3) pPaGFP synthesized without the presence of pPa; and (4) unmodified sfGFP synthesized
under otherwise identical conditions to other products. (Smith et al., 2013).
3.3.3

Click Immobilization
Preliminary click immobilizations to the beads exploring click conjugation efficiency were

performed using a small fluorescent ligand, Alexa Fluor® 555 alkyne (AF555). Click
conjugation was successful under multiple reagent concentrations as seen in Figure 3-4.
Reactions containing 1 nmol or more AF555 resulted in the highest amount of immobilization.
At 5 and 20 nmol AF555, the resulting attachment was not statistically higher than at 1 nmol (P
value = 0.78). This apparent maximum results in an average of 12 million AF555 per bead. The
number of AF555 attached and the percentage attached in Figure 2 are conservatively reported
and do not account for signal lost due to light diffraction and shadowing caused by the beads.
The number of AF555 attached and the percentage attached are conservatively reported above
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and do not account for signal lost due to light diffraction and shadowing caused by the beads.
Reaction conditions for pPaGFP immobilization were selected based on AF555 results.
pPaGFP were immobilized onto the azide-functional magnetic beads by anaerobic incubation
using reduced copper from either CuSO4 or tetrakis (acetonitrile)copper(I) hexafluorophosphate
(Cu(I)Tet) as a catalyst. The results are reported in Table 3-4. The Cu(I)Tet-catalyzed reactions
resulted in a higher click attachment percentage at 11% (9.6 million pPaGFP per bead),
compared to the CuSO4− catalyzed reactions at 4.5% (3.9 million pPaGFP per bead). The two
catalyst systems provide the essential catalyst (Cu(I)) with differing mechanisms. Cu(I)Tet
provides Cu(I) directly while the CuSO4 system relies on the redox potential of sodium
ascorbate to reduce Cu(II) to Cu(I). The divergence in catalyst-recovery mechanisms is a likely
cause for the mild divergence in overall reaction efficiency. While high reaction efficiencies are
reported in literature for similar click reactions using protein reagents (Hong et al., 2009; Li et
al., 2012; Patel and Swartz, 2011), the regent concentrations used in this work are at least an
order of magnitude lower. Excellent work by M.G. Finn's lab (Scripps Research Institute) has
demonstrated that the optimal copper catalyst concentration is dependent upon the reagent
concentration (Hong et al., 2009; Presolski et al., 2010). In addition, Finn and others have
reported a variety of ligands which improve the kinetics and reaction efficiency and the optimal
concentration of such ligands can depend on the reagent types and concentrations (Hong et al.,
2009; Presolski et al., 2010). Further work to optimize the click reaction at the lower
concentrations used in this work, could increase the reaction efficiency. However, we do
observed significant pPaGFP attachment with the reported reaction conditions.
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Figure 3-2: Alexa Fluor 555 and Bead Click-Conjugation Profile. The number of AF555
attached and the percentage attached are conservatively reported above and do not account for
signal lost due to light diffraction and shadowing caused by the beads. ‘‘Percentage AF555
Attached’’ refers to the percentage of AF555 attached compared to the amount input into the
reaction solution. No background attachment of AF555 to beads was evident under any of the
conditions considered. Error bars = standard deviation (n=2) or none (n=1). (Smith et al., 2013).
Adsorbed proteins were incubated with azide-decorated beads in the absence of copper and
then washed with PBS buffer in lieu of PBS-Tween buffer (n = 1). Similar trials washed in PBSTween buffer resulted in essentially no detectable adsorption (n = 2). See Supporting Information
After washing the beads with PBS-Tween buffer three times, nonspecific adsorption was
insignificant. However, washing with PBS only resulted in some nonspecific adsorption (0.5
million pPaGFP per bead as compared to 3.9 and 9.6 million pPaGFP per bead attached via click
conjugation).
The cyclo-addition of azides to nonactivated alkynes is Cu(I)-catalyzed to avoid high
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pressures and temperatures that would be incompatible with biological system (Prescher and
Bertozzi, 2005) However, copper ions can quench GFP fluorescence by direct, nondenaturing
interaction with the chromophore (Barondeau et al., 2002; Jung et al., 2005). In addition, it is
difficult to accurately assess the specific activity of the immobilized protein due to the
complicating factors of bead-induced light diffraction and shadowing, which may cause up to
50% signal reduction. However, based on the very conservative assumption that all active
pPaGFP on the bead were observed (i.e., no loss due to the bead-induced light diffraction and
shadowing), immobilized pPaGFP retained at least 40% of the activity of the free pPaGFP
incubated in the click reaction environment. For clarity, when reporting the stability of
immobilized pPaGFP and free pPaGFP under the harsh conditions below, changes in activity per
mol pPaGFP are reported to eliminate the impact of bead-induced signal loss factors.
Table 3-1: pPaGFP Attachment and Observed Activity Values
Unbounda
Incubated activity [RFU/mol
pPaGFP]
Bead-conjugated
Percent pPaGFP attached
Overall attached [million per
bead]
Observed activity attached
[RFU/mol pPaGFP]

CuSO4
37.0 ± 0.01

Cu(I)Tet
8.4 ± 3.0

PBS Buffer
109.7 ± 11.7

CuSO4

Cu(I)Tet

Adsorbedb

4.5% ± 1.2%

11.3% ± 3.5%

0.6%

3.9 ± 1.0

9.6 ± 3.0

0.5

15.6 ± 4.4

4.2 ± 1.9

12.0

For all data n = 2 with ± standard deviation unless specified.
a
Unbound protein were incubated in the respective reaction solutions and then assayed for
activity without beads present.
b
Adsorbed proteins were incubated with azide-decorated beads in the absence of copper and then
washed with PBS buffer in lieu of PBS-Tween buffer (n = 1). Similar trials washed in PBSTween buffer resulted in essentially no detectable adsorption (n = 2).
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3.3.4

Freeze Thawing
To evaluate if the immobilized pPaGFP exhibited improved stability, free pPaGFP and

bead-immobilized pPaGFP were subjected to multiple cycles of freezing and thawing. Changes
in pPaGFP activity were normalized per mol pPaGFP and are reported in Figure 3-5. The beadimmobilized pPaGFP activity increased slightly over the four freeze-thaw cycles. In contrast,
freeze-thawed free protein lost an average 17% of the initial activity after each cycle, resulting in
a 68% loss in activity after four freeze-thaw cycles. Free protein kept at 4°C over the entire
experiment also resulted in a drop in activity after four cycles. Free proteins subjected to freezethaw or maintained at 4°C in the presence of the copper-catalyst of the click reaction exhibited
very similar trends as their copper-free counterparts.

Figure 3-3: Freeze-thaw Effects on Stability. Bead-conjugated pPaGFP were run in parallel
through freeze thaw cycles (20 min at −80°C, 20 min at 25°C, assay, repeat) following which the
fluorescence activity was assayed. In addition, a control for the behavior of free pPaGFP
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consisted of free pPaGFP either freezethawed (solid line, circles) or maintained at 4°C (dashed
line, circles). Errors bars = standard error (n = 2 for beads, 26 for freeze-thawed, 50 for control).
(Smith et al., 2013).
3.3.5

Urea/Heat incubation
Bead-immobilized pPaGFP and free pPaGFP were incubated under the harsh conditions of

urea (6 M) and elevated temperature (50°C). Resulting changes in activity were normalized per
mol pPaGFP and are reported in Figure 3-6. Bead-immobilized proteins retained 57% or more of
their initial activity throughout the duration of the incubation in urea at 50°C. After the samples
were cooled to 4°C, the activity of immobilized pPaGFP recovered 83% or more of the initial
value, despite continued incubation in urea. In contrast, free pPaGFP retained <10% of their
initial activity during heating and after 12 h of cooling exhibited <3% of the initial activity,
regardless of urea's presence or absence.

Figure 3-4: Urea and Heat Effects on Stability. Bead-conjugated pPaGFP were run against
multiple controls and assayed for fluorescence. The solutions, with the exception of the free
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pPaGFP at room temperature, began at room temperature and were incubated at 50°C for the
duration of the assay directly after addition of room-temperature urea or water. The addition of
urea caused the free pPaGFP to drop in activity prior to any heating (empty circles). The beadimmobilized pPaGFP did not exhibit any immediate loss in activity due to the addition of urea
(empty squares/diamonds). Error bars = standard error (n = 2 for bead-conjugated pPaGFP, n = 3
for free pPaGFP, and n = 4 for free room temperature pPaGFP). (Smith et al., 2013).
3.4 Conclusion
We have introduced an example of Protein Residue-Explicit Covalent Immobilization for
Stability Enhancement or PRECISE system. Click chemistry teamed with minimally invasive
site-specific uAA-incorporation using cell-free protein synthesis allowed for the rationally
engineered protein to be directly and site-specifically immobilized onto an inorganic surface. In
all cases explored here, the immobilized pPaGFP appeared to exhibit superior stability, durability
and retained activity during multiple harsh scenarios as compared to free protein in solution.
The ability to site-specifically attach proteins to a surface using bio-orthogonal chemistry at any
predetermined site has provided a basis for more stable and longer lasting protein activity. This
technology has numerous implications in the industrial, scientific and medical communities and
could be applied to enhance industrial enzyme recovery, simplify laboratory assays and
machinery, and reduce medical diagnostic costs while increasing consistency, availability and
transportability. Furthermore, this work solidifies the foundation for the PRECISE system for
highly stable protein immobilization.
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4.
Enhancing Candida antarctica Lipase B Activity, Stability, and Reusability Through
Rationally Directed, Site-specific Immobilization
4.1

Introduction
Chemical catalysis provides one of the foundational blocks upon which the $812 billion

American chemical industry is built (based on 2014 American Chemistry Council estimates).
Due to the increased demand for environmentally friendly, sustainable, and highly specific
chemical manufacturing processes, biocatalysis is rapidly growing as a replacement for
traditional catalytic techniques (Clark, 2009). Enzyme catalysis has several advantages that
make it particularly suited for chemical manufacturing purposes: biocatalysts are biodegradable,
non-toxic, can be performed in aqueous conditions and at ambient temperatures, are
reusable/recoverable, do not require toxic reagents, and are highly specific (Alcalde et al., 2006;
Sheldon, 2007). Further growth in the biocatalysis industry relies upon solutions to a few
enzyme use challenges, primarily, the need to maintain enzyme stability over time and enzyme
catalyst recoverability and reusability (Ragauskas et al., 2006). One solution to the difficulties of
increasing enzyme stability over time and enzyme recoverability and reusability is the
immobilization of enzymes on a surface or carrier.
Enzyme immobilization has been shown in many instances to increase enzyme stability
and recoverability/reusability (Sheldon, 2007). Moreover, enzyme immobilization greatly
simplifies enzyme recoverability and reuse, greatly reducing the cost of enzyme use over time.
The most common enzyme immobilization techniques, utilizing adsorption and ionic
immobilization processes, have enabled greater enzyme recoverability and reuse but are limited
by the issues of enzyme stability and leaching over time. Covalent enzyme immobilization
resolves the issue of enzyme leaching and improves enzyme stability but like both adsorption
and ionic immobilization, do not enable immobilization orientation control.
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Although the importance of enzyme immobilization orientation control has been suggested
by molecular modeling simulations and in a limited fashion by previous enzyme immobilization
technologies that limited potential immobilization sites, covalent immobilization orientation
control has not been thoroughly studied (Tanaka et al., 2007; Wei and Knotts, 2011a). Previous
site-specific immobilization techniques have relied on techniques such as global replacement or
N- or C-terminus immobilization that do not permit adequate testing of the impact of
immobilization orientation on enzyme activity (Gauchet et al., 2006; Tanaka et al., 2007). Here,
we introduce a covalent, site-specific, rationally-directed enzyme immobilization technique
utilizing non-canonical amino acid incorporation and the 2,3-dipolar Huisgen cycloaddition
“click reaction” to enable complete enzyme immobilization orientation control.
Background
Candida antarctica Lipase B or CalB (EC 3.1.1.3) is an industrially relevant biocatalyst
that enables a variety of biotransformations and has particular importance for organic synthesis
(cite One Biocatalyst – many applications). CalB activity is not inhibited by the “click” reaction
conditions and therefore is a compelling candidate for “click” reaction exploration (Schoffelen et
al., 2008b). The enzyme is active as a single protein, and does not form multi-mers that might
skew attachment results. Also, CalB has a simple, highly sensitive and widely accepted assay for
activity, which is easily compared to standard, commercially available lyophilized enzyme
(Sigma-Aldrich). A recent article described immobilizing CalB with unnatural amino acids, but
used a global replacement method (Kiick et al., 2002; Schoffelen et al., 2008a). To avoid such
invasive changes we site-specifically incorporated an alkyne-terminally functionalized unnatural
amino acid (p-propargyloxyphenylalanine, pPa) at only the desired location for attachment.
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4.2

Materials and Methods

Prepare Azide Functionalized Superparamagnetic Beads
Terminal amine group functionalized superparamagnetic M-270 Dynabeads were
purchased from Invitrogen. The beads were then modified using a procedure adapted from
literature to replace the amine functional groups with azide functional groups that could be used
for click conjugation (Figure 4-1) (Punna et al., 2005). First, 5-azidopentanoic acid 4nitrophenyl esters were synthesized through the addition of 5-azidopentanoic acid (3.5 mmol)
and p-nitrophenol (3.7 mmol) to a solution with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
hydrochloride (3.7 mmol) in CH2Cl2 at room temperature overnight.

Figure 4-1: Organic synthesis steps used to modify amine-functionalized Dynabeads with
terminal azide functional groups.
Using flash silica chromatography, the 4-nitrophenyl ester was purified and verified by
Maldi-Tof mass spectrometry. Post-purification, the 4-nitrophenyl esters dried, dissolved in
DMF, and added to a tube containing 2 ml of Dynabeads (2x109 beads per ml) in 5% MES buffer
and stirred gently at room temperature for two days. The reaction mixture containing the
functionalized beads was washed repeatedly with PBS buffer and transferred into a clean vial.
Measurement of the p-nitrophenol absorbance using the optimal 412 nm wavelength was
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performed and compared with a p-nitrophenol standard curve. A negative control reaction
without beads was performed, with no change in absorbance at 412 nm.
The Dynabead manufacturer specifications note there are 0.1 mmol terminal amine
groups per gram of dry beads and 7x1010 beads per gram dry beads. Relying on an assumption
that the superparamagnetic beads are smooth spheres as shown in manufacturer provided
literature, this suggests that there are approximately 35 terminal amines sites per nanometer
squared. This high packing density conclusion was supported by the p-nitrophenol assays, which
resulted in 95% conjugation or approximately 33 terminal azide groups per square nanometer.
The density of the amine functionalized groups may be overestimated due to the unevenness
and/or porosity of the polymer coating on the magnetic cores. The smooth sphere assumption is
based upon images provided in manufacturer literature and used to clarify calculations.
4.3

Production of Candida antarctica Lipase B with Non-canonical Amino Acids
As discussed above, CalB was modified in a recent study for immobilization through the

use of unnatural amino acids, but this was performed using a global replacement method that
required the replacement of five amino acids (Schoffelen et al., 2008a). In this study, the five
methionines were replaced by azidohomoalanine for conjugation purposes. For this enzyme, the
modifications altered enzyme activity by >25%. However, for other enzymes, such extensive
modification of the wild-type enzyme might have more substantial implications for enzyme
activity, which would likely reduce its effectiveness as an alternative to traditional enzyme
immobilization techniques. Moreover, this technique does not permit enzyme immobilization at
rationally directed residues throughout the enzyme but rather limits immobilization to sites
where a specific amino acid residue to be replaced may be found.

48

In contrast, the covalent enzyme immobilization technique that we have developed
enables site-specific enzyme immobilization at residues throughout the enzyme while requiring
only the change of a single amino acid residue through the substitution or insertion of a noncanonical amino acid. Through careful site-selection, the effects of enzyme modification can be
minimized. This is supported by evidence in this study and more thoroughly in the lysozyme
chapter below.
The non-canonical amino acid, p-propargyloxyphenylalanine, was site-specifically
incorporated through the use of the E. coli-based cell-free protein synthesis as illustrated in
Figure 4-2. Although a similar system was used previously to produce green fluorescent protein
and is used later to produce lysozyme, significant differences between GFP, CalB, and lysozyme
necessitated different approaches to protein production.
Unlike GFP, which may be produced in the E. coli cell-free protein production
environment without significant cell extract modification, CalB is a eukaryotic yeast protein that
suffers from significant solubility issues in an unmodified crude extract (Park et al., 2009a). The
primary difficulty in CalB production results from the reductive nature of the unmodified E. coli
cell-free extract. The reducing nature of the extract as well as the presence of many E. coli
cysteine peptidases inhibits proper disulfide bond formation in CalB. As three disulfide bonds
are necessary for CalB to fold correctly, obstacles to formation of any or all of the three bonds
increase the risk of enzyme insolubility. Additionally, many non-canonical amino acids, such as
the one utilized here, also suffer from solubility issues, increasing the difficulty of non-canonical
amino acid insertion into a cell in vivo (Liu and Schultz, 2010). Fortunately for CalB protein
production purposes, the versatility of the cell-free system enables us to overcome these
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solubility issues and simplifies the addition of non-canonical amino acids for insertion into the
protein production environment.
E. Coli
Tyr
MjtRNA CUA

MjTyrRSpPa
HO

pPa

NH2
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HO

NH2
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Figure 4-2: E. coli-based cell-free protein synthesis system modified for Candida antarctica
Lipase B production.
4.3.1

Modifying the Cell-free Environment to Promote Disulfide Bonds
While in vivo protein production must be tempered to enable continued cell viability,

cell-free protein synthesis systems permit protein production environments that may include
extreme acidity or alkalinity, redox potentials, ionic strengths, or other conditions that would be
otherwise inimical to cell survivability. Given the reducing nature of the crude E. coli extract,
the literature described three key methods of increasing CalB solubility: 1) the addition of
compounds to oxidize the crude cell extract, 2) the inhibition of the activity of endogenous E.
coli cysteine peptidases using molecular inhibitors, and 3) the supplementation of the extract
with chaperone proteins that enable the proper folding and formation of the lipase. These tests

50

were key to CalB protein production due to the fact that only 5% of the total CalB produced in
our unmodified crude extract CFPS reactions were soluble.
For the first technique, prior work by the Kim group demonstrated that CalB solubility
may be catalyzed by adding oxidized and reduced glutathione to the reaction solution in the ratio
of 4 mM to 1 mM (Park et al., 2011a). We evaluated this recommendation in comparison to
many other oxidized/reduced glutathione concentrations such as 3 mM/1 mM, 5 mM/1 mM, 8
mM/2 mM ratios and discovered that this was indeed the optimal reaction concentration (data not
shown). This concentration was then used for all reported CalB reactions.
The second technique of inhibiting the activity of E. coli cysteine peptidases was used by
preincubating our crude extracts with iodoacetamide. 2-iodoacetamide inhibits the activity of all
cysteine peptidases. Based on preliminary tests, iodoacetamide provided slight increases in
lipase activity, but did not prove as advantageous as hoped. This is likely due to the fact that the
use of iodoacetamide requires a balancing act, as insufficient iodoacetamide fails to inhibit a
sufficient percentage of cysteine peptidases, while an excess of iodoacetamide may inhibit
disulfide bond formation through thiol interactions with the cysteines in the enzyme.
GroEL and GroES are chaperone proteins found in some strains of E. coli. The two
proteins combine to form a complex that combine to encapsulate the folding protein, enabling
proper protein folding (Figure 4-3). Although not specific to CalB, our tests demonstrated that
the addition of a specially modified extract containing GroES and GroEL to the cell-free protein
production reactions significantly improved protein solubility. After addition of GroES and
GroEL, test results demonstrated that solubility increased from 5% of the produced protein to
over 50% of all produced protein.
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Figure 4-3: The GroEL and GroES Complex. It consists of the GroES cap (labeled in red and
yellow) as well as the GroEL complex (labeled in blue, purple, and green) (Goodsell, 2002).
4.3.2

Selection of Non-canonical Amino Acid Incorporation Sites
Given that the goal of non-canonical amino acid incorporation was to test the effect on

stability and activity of enzyme immobilization at various sites throughout the enzyme, we
carefully selected three locations for study that varied greatly from one another. The three
chosen locations were a site near the N-terminus, a site near the C-terminus, and a third site near
the active site (Figure 4-4). The N-terminus site between Lys2 and Leu3 was chosen for study
due to its importance as a region that is often heavily modified in enzymes. The C-terminus site,
substituting pPa for Val196, was viewed as a site where the protein crystal structure
demonstrates that the non-canonical amino acid would be on a loop that is readily available for
enzyme immobilization and that is part of a long loop region that is less significant for protein
structural stability.
Although the specially prepared GroEL and GroES extract greatly alleviated the issue of
solubility, it increased the complexity of CalB preparation. The production of CalB with noncanonical amino acids requires the inclusion of special Methanocaldococcus jannaschii tRNA
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and tRNA synthetases that are able to recognize and incorporate the non-canonical amino acid
(Bundy and Swartz, 2010). After significant testing, it was observed that overexpression of both

A)

Active Site

B) Active Site

C)

Active Site
Figure 4-4: Non-canonical amino acid incorporation sites. A) pPa incorporation at the Nterminus between Lys2 and Leu3. B) pPa incorporation at the C-terminus as a substitution for
Val196. C) pPa incorporation near the active site between Asn98 and Asn99.
GroES and GroEL proteins as well as the Methanocaldococcus jannaschii proteins in the same
extract inhibited E. coli growth and reduced the viability of the cells and of the cell extract.
Consequently, various proportions of GroEL/GroES cell extract combined with pEVOL extract
containing the Methanocaldococcus jannaschii tRNA/tRNA synthetase pairs were tested to
evaluate the optimal ratio for maximum CalB protein production (Figure 4-5).
The prototypical cell-free reaction, used for the production of GFP above and lysozyme
below, utilizes a 15% volume to volume ratio of cell-free extract. However, given the solubility
difficulties found in producing CalB, a mixture ranging from 25% v/v extract up to 45% v/v
extract per batch reaction was tested. As the GroEL/ES extract v/v percentage increased from
15-20 percent, the amount of soluble protein produced increased significantly. Changing the
pEVOL extract percentage from 15 up to 25 percent also led to substantial improvements in
overall protein production, both soluble and insoluble (Figure 6-5). The combination of
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Figure 4-5: Wild-type CalB Production. Demonstrates total and soluble protein yields utilizing
various ratios of GroEL/ES E. coli extract and pEVOL E. coli extract.
pEVOL extract with GroEL/ES E. coli extracts enabled recovery of greater than 75% of the total
protein production in the soluble fraction.
The site-specific incorporation of non-canonical amino acids utilizing the amber codon
replacement system described previously produces two types of proteins: full-length proteins
with the non-canonical amino acid and truncated proteins without the amino acid (Smith et al.,
2013). To quantify the amount of protein being produced and to ensure that full-length CalB
was being produced by our system, we radiolabeled our proteins using 14C leucine. These radiolabeled proteins were then run on an SDS-PAGE protein gel (NuPAGE, Invitrogen) and an
autoradiogram was performed (Smith et al., 2013). Prior reports have demonstrated findings of
less than 1% read-through when the non-canonical amino acid is not included in the protein
production reaction and that greater than 99% of the produced protein is truncated in the absence
of the unnatural amino acid (Wang et al., 2006). These results are supported by our findings
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(Figure 4-6). As we had previous incorporated pPa in GFP, it is used as a control here. No fulllength GFP or CalB is seen in the absence of pPa. The truncated product for the K2 CalB variant
does not contain any leucines and thus was not visible on the autoradiogram. The N98 CalB
variant contains only a few leucines and thus, its truncated product was also not observed.
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Figure 4-6: Autoradiograms of wild-type (wt) and pPa-incorporated GFP and CalB. A. An
autoradiogram showing the effect of the addition and absence of pPa, with all observable protein
truncated in the absence of the non-canonical amino acid at position 216. B. An autoradiogram
showing full-length and truncated protein in the presence and absence of pPa. pPa is inserted
after N98 and K2 and is substituted for V196.
Strep-tags were added onto the C-terminus of each CalB variant to enable purification of
the full-length protein. Post-verification, strep-tactin columns (IBA Scientific, Goettingen,
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Germany) were used to separate out the wtGFP, pPaGFP, wtCalB, K2 pPaCalB, N98 pPaCalB,
and V196 pPaCalB using the manufacturer’s protocols.
4.4

Covalent Site-specific “Click” CalB Immobilization on Superparamagnetic Beads

Figure 4-7:
CalB Click Immobilization Scheme. The terminal alkyne group of the pPa
enables covalent conjugation with azide functional groups on the surface of the
superparamagnetic bead. Due to the site-specific incorporation of the amino acid, the enzyme’s
immobilization orientation is equivalent in each and every instance.
Our prior work optimizing click conjugation of Invitrogen’s Alexa Fluor 555 (AF555)
alkyne fluorophores and pPaGFP to superparamagnetic beads was adapted for application with
CalB (Figure 4-7). Based on our success using 1 mM tetrakis(acetonitrile)copper(I)
hexafluorophosphate (hereafter “Cu(I)Tet”), this copper catalyst was used again in the same
concentration. However, due to the larger size of CalB compared with pPaGFP and AF555, the
ratio of active site to enzyme was increased to prevent oversaturation of enzyme in the “click”
reaction. For the “click” reactions, 0.06 nmol CalB was added to 1 mM Cu(I)Tet and beads
equivalent to 10 nmol azide active sites were added and incubated in an anaerobic environment
for 48 hours. Using liquid scintillation counting, click conjugation efficiency on the beads was
11%% ± 0.5% standard deviation (n=2).
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4.5

In Solution and Immobilized CalB Variant Activity
The activity of the CalB variants were compared in solution and when immobilized. The

CFPS-produced enzymes were compared to a commercially available CalB enzyme purchased
from Sigma-Aldrich. The enzyme assay was performed based on a previously reported
procedure which consisted of adding 0.05 mM p-nitrophenyl palmitate and ethanol (4% v/v) to a
solution of 50 mM Tris-Cl buffer pH 8.0 (Park et al., 2009a).

Figure 4-8: Specific Activity of Commercial CalB and CalB Variants. “Commercial” refers to
commercial CalB purchased from Sigma-Aldrich. Wild-type CalB is labeled “wt,” CalB with
pPa inserted after K2 is labeled “K2,” CalB with pPa inserted after N98 as “N98,” and CalB with
pPa replacing V196 is labeled “V196.” Please note that all error bars denote standard deviation,
n = 3. CalB attached to beads for K2 and N98 has activity measured n=1. The specific activity
of V196 post “click” attachment was not measured.
Equivalent reaction mixtures were used for all variants, in solution or immobilized. The insolution and immobilized enzymes were added to the reaction mixture for a total volume of 60 µl
in trUView cuvettes (Bio-Rad, Hercules, CA). As CalB converts p-nitrophenyl palmitate to p-
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nitrophenol, producing an absorbance change at 405 nm, the CalB variants were incubated at
37°C and the change in absorbance was measured in a Genesys 10S UV-Vis Spectrophotometer
(Thermo Scientific, Waltham, MA) after 30 minutes. Using a standard definition for activity
units, a unit was defined as a 1 µmol increase in p-nitrophenol per minute per mg enzyme
(Figure 4-8).
Measurement of the activity of CalB variants pre- and post-immobilization showed
positive results. For variants K2 and N98, the change in activity post-immobilization was
relatively minor and within a standard deviation. This suggested that CalB might be a positive
candidate for covalent conjugation as it retained a significant amount of activity postimmobilization.
4.6

Conclusion: CalB Challenges, Lessons Learned
Although the process of producing the eukaryotic protein CalB and immobilizing it was a

great learning process that proved very valuable for lysozyme immobilization studies below, it
was one filled with many difficulties. It was very costly and time-consuming to produce
sufficiently large and active concentrations of CalB in order to successfully immobilize it on the
superparamagnetic bead surface. CalB yields in cell-free batch reactions were much lower than
those of pPaGFP. Further, strep-tag purification of CalB seemed relatively inefficient, producing
low post-purification yields. Given the low yields of CalB, which greatly increased the cost of
CalB immobilization, the decision was made to switch to an enzyme that could more easily be
produced at significant yields in the E. coli cell-free protein synthesis system. The decision to
choose T4 bacteriophage lysozyme is discussed in the next chapter. Despite this, the valuable
lessons learned about CalB production, solubility, and viability in the cell-free protein synthesis
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system would prove to be an important component of a paper for which I was a coauthor, but
which I do not include here (Smith et al., 2014)
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5.

Enhanced Enzyme Stability Through Site-Directed Covalent Immobilization
Much of this chapter (see Section 5.1 to 5.4) is an adaptation from an article titled

“Enhanced Enzyme Stability Through Site-Directed Covalent Immobilization” that was recently
accepted for publication by the Journal of Biotechnology. This work was developed and led by
myself with the assistance of three undergraduate students, Mark Lindsay, Christopher
Hutchings, and Christopher Werner. However, it is prefaced by a discussion not included in the
paper establishing the rationale behind the selection of T4 bacteriophage lysozyme as an enzyme
for study as well as an evaluation of the molecular modeling studies that have previously been
performed on this enzyme. A further discussion of the lessons learned from comparing
molecular modeling in silico techniques with in vitro techniques is provided in the next chapter.
5.1

Introduction
According to Environmental Protection Agency statistics, the U.S. alone contains more

than 13,500 chemical manufacturing facilities providing shipments valued at over $555 billion
annually (EPA, 2011). Unfortunately, traditional chemical manufacturing processes often require
the use of toxic reagents, strong acids and bases, and have high energy costs while suffering from
low product specificity. These processes produce more than 1.5 million tons of air pollution and
over 10 billion pounds of solid waste annually, much of it toxic (EPA, 2011).
A more environmentally friendly alternative to conventional processes is the use of
biocatalysts, or enzymes, to catalyze reactions (Bornscheuer et al., 2012). Enzyme use
eliminates the need for many toxic reagents, enables reactions to be performed in aqueous
conditions at ambient temperatures, and reduces the need for purification while providing high
chemo-, regio-, enantio-, and stereo-specificity (Sheldon, 2007). These advantages have fueled a
7.5% annual growth rate in the industrial enzyme biocatalysis market from 1995 to 2012 (240%
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total increase in market share) such that enzyme biocatalysis represented 10% of the global
catalysis market in 2012 (Kirk et al., 2002; Milmo, 2012) However, enzymes have their own
unique set of challenges including the following: enzyme production costs, enzyme stability, and
enzyme recoverability and reusability (Wang et al., 2009b).
Enzyme immobilization provides a simple and elegant solution to these challenges. It
enables recovery and reuse of the biocatalysts, significantly driving down the biocatalyst cost
over many reactions. Currently, a number of different enzyme immobilization techniques are
being used in industry such as enzyme adsorption, entrapment, and cross-linking (Sheldon,
2007). A particularly attractive method is attachment/adsorption of the enzyme to the surface of
a carrier which commonly results in enhanced enzyme stability (Alonso et al., 2005; Anwar et
al., 2007; López-Gallego et al., 2005; Mozhaev et al., 1990; Qiu et al., 2005; Rocchietti et al.,
2004). Stability enhancements have been shown after attachment to many different carriers,
examples include including magnetic beads (Qiu et al., 2005), mesoporous sol-gel glass (Wang et
al., 2001b), silica nanospheres (Wang and Caruso, 2004), Sepabeads (Rocchietti et al., 2004),
agarose (Rocchietti et al., 2004), and protein-coated microcrystals (Kreiner and Parker, 2005).
Many different conjugation chemistries have been used, relying on amine, epoxy, maleic
anhydride, glyoxal, biotin/streptavidin, and many other reactive functional groups for enzyme
immobilization (Leckband and Langer, 1991; López-Gallego et al., 2013; Maeda et al., 2008;
Mateo et al., 2007a; Mazi et al., 2006; Tasso et al., 2009; Zhang et al., 2011a) The chemical
interactions used for surface attachment/adsorption may primarily be divided into three
categories, Van der Waals-based adsorption, ionic adsorption, and covalent attachment (Sheldon,
2007).
Van der Waals enzyme adsorption techniques have been successfully used in industry,
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but because these intermolecular forces are weak in comparison to ionic or covalent bonds,
significant leaching of the enzyme from the support occurs over time (Zhao et al., 2006). Ionic
adsorption improves retention over Van der Waals interactions, but leaching to a lesser extent is
still common (Kirk and Christensen, 2002). Covalent immobilization is best suited for
producing the strongest and longest lasting bonds between enzymes and surfaces, however it is
the most prone to undesired surface-enzyme interactions resulting in activity loss (Barbosa et al.,
2014; Kim et al., 2006a; Klibanov, 1979; Mateo et al., 2007b; Mozhaev et al., 1990).
Traditionally, all of these techniques are limited in their inability to control the orientation at
which the enzyme attaches/adsorbs to the surface to minimize undesired enzyme-surface
interactions, maximize enzyme stability, and maximize active-site accessibility (Hernandez and
Fernandez-Lafuente, 2011; Mateo et al., 2007b).
The development of technologies to enable site-specific enzyme immobilization at any
desired residue on the protein would enable virtually all options. Prior modeling research has
predicted that certain attachment sites can minimize undesired enzyme-surface interactions and
optimize thermodynamic stability of immobilized proteins and enzymes (Friedel et al., 2007;
Talasaz et al., 2006; Wei and Knotts, 2011b; Zhuoyun et al., 2009). Moreover, careful
immobilization orientation control can minimize the effects of steric hindrance of the enzyme
active site post-immobilization and provide greater understanding of the enzyme-surface
interactions.
Previous research demonstrating covalent site-specific immobilization techniques have
suffered from significant limitations in potential immobilization locations, such as the N- or Cterminal regions (Smith et al., 2005; Tominaga et al., 2004). Other site-specific immobilization
technologies have enabled immobilization at many potential residues, but rely on noncovalent
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techniques (Kalia et al., 2007; Lim et al., 2014; Seo et al., 2011). To our knowledge, no covalent
site-specific immobilization method has been previously demonstrated enabling immobilization
at residues throughout the enzyme while only requiring a single substitution or insertion. In this
paper, we seek to address the need of a covalent site-specific system enabling immobilization at
potential residues throughout the enzyme to prevent enzyme leaching and also analyze the
impact of immobilization orientation on enzyme stability.
Here, we report our PRECISE system’s (Protein Residue-Explicit Covalent Immobilization
for Stability Enhancement) (Smith et al., 2013) effective application for covalent, site-specific
immobilization and increased stability of enzymes. This system facilitates easy, non-invasive
enzyme recoverability and reusability, testing of enzyme activity at different immobilization
sites, and comparisons of enzyme stability when attached at different orientations. These
benefits are accomplished through the use of amber-codon-substitution to enable rationallydirected non-canonical amino acid incorporation for site-specific enzyme immobilization using
the covalent, biocompatible, and bioorthogonal Huisgen 1,3-dipolar cycloaddition reaction
(Boyce and Bertozzi, 2011; Hong et al., 2010; Smith et al., 2013; Young et al., 2010). The
results from these tests indicate that enzyme immobilization orientation plays a significant role in
enzyme activity and stability and that meaningful stability enhancements above and beyond that
provided by immobilization alone can be found through careful immobilization orientation
control.
5.2 Selection of Model Enzyme for Study
Lysozyme was chosen for study because of its well-characterized folding and
denaturation pathways (Peng and Li, 2008; Wildegger and Kiefhaber, 1997). T4 bacteriophage
lysozyme is a molecule that is 164 residues in length, and is classified as an orthogonal-bundle
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protein that is primarily alpha in nature. It is a multistate folding protein that follows a slowfolding pathway 20% of the time, leading to a stable intermediate (Kiefhaber, 1995). In the
remaining 80% of folding opportunities, the protein follows a quick-folding pathway where it
folds quite rapidly and does not form a stable intermediate (Kiefhaber, 1995). However, the
presence of a stable intermediate has complicated understanding of lysozyme folding. Due to
computational limitations, molecular modeling of surface-protein and surface-enzyme
interactions have relied until recently on two-state folding mechanism models for proteins (Wei
and Knotts, 2011b). Models that rely on two-state folding mechanism are sufficient for some
proteins (Zwanzig, 1997) that exist primarily in folded or unfolded states but lack the ability to
effectively evaluate proteins with complicated transition states.
Recent improvements in molecular modeling systems now enable the study of proteins
with multiple folding states, enabling the evaluation of enzymes such as lysozyme with a stable
intermediate. These recent improvements enabled the recent evaluation of the effects of
tethering lysozyme to a surface (Wei and Knotts, 2011b). This molecular modeling of T4
lysozyme relied on a course-grain model with a short-range repulsive surface that evaluated the
interaction of the enzyme with the surface only when a single residue came into close proximity
with the surface (Wei and Knotts, 2011b). Although this in silico approach is greatly simplified,
it enables molecular modeling studies of a system very similar to the PRECISE site-specific
system described herein where our protein or enzyme of interest is immobilized at a single site or
residue, and the interaction between the protein and surface occurs primarily in this region.
Building upon this molecular modeling approach with a real-world experimental study of
lysozyme is necessary because even the most current of molecular modeling technologies relies
on significant simplifications of many factors that can affect enzyme stability such as
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interactions between the enzyme and the solvent, the interactions between the solvent and the
surface, interactions between neighboring proteins, interactions between neighboring surfaces,
and any and all combinations of all of these interactions. Conclusions about the thermodynamic
stability of a single protein interacting with a single surface may or may not prove equally true
for industrial applications that rely on the immobilization of many enzymes on a surface with the
many combinations of interactions discussed above. In contrast, experimental validation of
conclusions made from molecular modeling systems may demonstrate that despite the
simplifications made in molecular modeling, these thermodynamic models provide relatively
robust systems for analysis and provide a strong foundation for future experimental testing.
Here, Shuai et al. predicted that the immobilization of lysozyme at residue 91, a leucine,
would provide a particularly thermodynamically stable conformation, enhancing lysozyme
stability above that of its unimmobilized form found in solution (Wei and Knotts, 2011b). In this
simulation, the researchers observed an interesting result, namely that immobilization of
lysozyme at this residue eliminated the stable intermediate as one of the possible folding states,
converting lysozyme into a two-state folding protein. This stable intermediate involves the
separation or breaking away of the first, structurally important alpha helix from the rest of the
enzyme. The elimination of this stable intermediate reduces the number, types and stability of
misfolded and incompletely folded lysozyme states, thus, significantly increasing the overall
stability of the lysozyme when tethered at site 91. Based on this finding, leucine 91 was
carefully chosen as one of the sites for examination in our study.
As a noteworthy change, however, our study goes beyond the examination of the
previous molecular modeling study in that we evaluate enzyme stability not only within the
context of enzyme stability in a heat and temperature context but stability in the presence of
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chemical denaturants, notably urea. Due to the marked differences in destabilizing effects
played by chemical denaturants as opposed to the effects caused by temperature, this was also
deemed a fruitful area of study.
5.3

Materials and Methods

5.3.1

Cloning
A T4 lysozyme variant (Plasmid 18111) with two mutations, C54T and C97A, but

equivalent activity and stability to the wild-type lysozyme was acquired from Addgene
(Cambridge, MA) (Matsumura and Matthews, 1989). This T4 lysozyme variant simplified cellfree protein synthesis (CFPS) because it eliminated the need to alter the environmental redox
potential to promote disulfide bond formation (Matsumura and Matthews, 1989). As an
additional benefit, the denaturation pathway of this variant has been well-characterized (Peng
and Li, 2008).
For protein purification purposes, a strep-tag (consisting of the eight amino acids TrpSer-His-Pro-Gln-Phe-Glu-Lys) was added to the C-terminus of the cysteine-free T4 lysozyme
using the Quikchange II mutagenesis protocol (Agilent Technologies, Santa Clara, CA). This T4
lysozyme is hereafter referred to as the “standard” lysozyme. Six sites were selected for
modifications to enable non-canonical amino acid incorporation at each site and immobilization
at that site. These sites were T21, K35, N53, L91, K135, and K162 and the Quikchange II
mutagenesis protocol was used to substitute the amber stop codon at each location (Figure 5-1A).
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Figure 5-1: Site-specific vs. Nonspecific Covalent Immobilization. A. Location of six different
non-canonical amino acid incorporation sites tested as potential immobilization sites. B. T4
lysozyme structure showing all possible nonspecific immobilization attachment sites at arginines
(red), lysines (blue), and the N-terminus (green). C. The PRECISE System attachment scheme
utilizing non-canonical amino acid incorporation and the Huisgen 1,3-dipolar cycloaddition
(“click” reaction) to site-specifically covalently immobilized enzymes on superparamagnetic
beads. D. Nonspecific covalent immobilization scheme using epoxy-functionalized beads
treated to bind to reactive amines. E. Autoradiogram demonstrating lysozyme variant protein
production when the non-canonical amino acid is added to the cell-free protein synthesis
reaction. F. Autoradiogram demonstrating that full-length lysozyme variant production was not
detected when the non-canonical amino acid was not added. Note the truncation band for K162
is due to termination of the protein at the amber stop codon, which is only 10 codons from the Cterminus. As all produced proteins were subjected to a strep-tag purification process where such
strep-tag was located on the C-terminus of the lysozyme, only full-length proteins were
recovered and used for further experiments. (Wu et al., 2015).
5.3.2

Cell-free Protein Synthesis
The Escherichia coli cell-free protein synthesis system is a protein production technology

particularly valuable for its scalability (Zawada et al., 2011). Previously researchers have
demonstrated equivalent protein production from the 100 μl to the 100 liter scale (Zawada et al.,
2011). Here, CFPS reactions for protein production were performed as described previously
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(Smith et al., 2013). The cell-free extract was prepared as described previously (Shrestha et al.,
2014) and was produced from a BL21 StarTM (DE3) E. coli strain purchased from Invitrogen
(Carlsbad, CA) harboring the pEVOL-pPrF plasmid, a kind gift from Peter Schultz, (Scripps
Research Institute). For cell-free reactions for lysozyme variants incorporating non-canonical
amino acids, 2 mM p-propargyloxyphenylalanine (pPa) and 3 mg/ml pPa specific
Methanocaldococcus jannaschii pPa tRNA-synthetase were additionally added (Smith et al.,
2013). Post-cell free reaction, lysozyme was purified from the CFPS reaction using StrepTactin Superflow columns (IBA Life Sciences, Gottingen, Germany). The lysozyme variants
were quantified as described below.
5.3.3

Protein Yields
The yields for the total and soluble protein were calculated using liquid scintillation as

described previously (Smith et al., 2013). Full-length protein production was verified by running
sodium dodecyl sulfate polyacrylamide gel electrophoresis, followed by autoradiography as
previously reported (Smith et al., 2013). In all reactions where the non-canonical amino acid
was not added, all T4 lysozyme proteins were truncated and no full-length protein was observed
(Figure 5-1F). In contrast, where the non-canonical amino acid was added, full-length T4
lysozyme was produced (Figure 5-1E). Once full-length protein production was verified, soluble
proteins were recovered from the supernatant post-centrifugation at 13,000 x g for 15 minutes
and purified by strep-column purification per the manufacturer’s specifications (IBA Life
Sciences, Goettingen, Germany).
5.3.4

Enzyme Immobilization on Superparamagnetic Beads
Nonspecific covalent lysozyme immobilization was performed using M-270 Epoxy

Dynabeads (Life Technologies, Carlsbad, CA). (Figure 5-1D). The manufacturer specified
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protocol was used for immobilization. This immobilization method enables covalent
immobilization at all arginines, lysines, and the N-terminus (Figure 5-1B). 200 µl reactions were
used with 300 µM of available epoxy sites and 3 µM lysozyme. The immobilization of the
enzyme was verified by liquid scintillation counting of C14 leucine-radiolabeled lysozyme.
For site-specific attachment, the Huisgen 1,3-dipolar “click” reaction was used (Figure 5-1C).
Click reaction conditions consisted of 2 mM CuSO4, 10 mM sodium ascorbate, 4 µM THPTA,
300 µM of azide functionalized M-270 Amine Dynabeads as discussed previously, and 3 µM of
lysozyme with a total reaction volume of 200 µl (Smith et al., 2013). The reaction was added
into a 1.5 ml microcentrifuge tube and rotated end over end for 24 hours at 4ºC. Enzyme
immobilization was verified by liquid scintillation counting of C14 leucine-radiolabeled
lysozyme.
5.3.5

Purification of Lysozyme Immobilized Dynabeads
Immobilized lysozyme was purified using the following procedure. Microcentrifuge

tubes containing reaction mixtures were centrifuged and placed on a Dynaspin Magnet (Life
Technologies) for 8 minutes to ensure that all beads were firmly pulled to the microcentrifuge
tube sidewalls by the magnet. All reaction reagents except the beads were removed by careful
pipetting. Next, careful washing of the beads to remove noncovalently immobilized lysozyme
was performed and the buffer was exchanged four times repeating the following procedure. First
the beads were resuspended with 100 µl of PBS buffer at 4ºC and vigorous vortexing. After
vortexing, the beads were incubated for 15 minutes at 4ºC. Samples were then returned to the
DynaMag Spin Magnet and the supernatant removed by pipetting. After the final washing step
was complete, the beads were resuspended and subsequently stored at 4ºC in the Enzchek
Lysozyme Assay reaction buffer (Life Technologies, Carlsbad, CA). 1x Enzchek Lysozyme
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Activity Assay reaction buffer (hereafter referred to as “assay reaction buffer”) consists of 0.1 M
sodium phosphate, 0.1 M sodium chloride, and 2 mM sodium azide at a pH of 7.5.
Liquid scintillation counting demonstrated that on average 7.7±0.96% of the lysozyme added to
the immobilized reaction was conjugated on the superparamagnetic beads. Using surface area
data provided by the manufacturer and conservatively assuming that lysozymes would
horizontally orient in the most space-saving fashion, it was estimated that at the average coupling
efficiency of 7.7%, immobilized lysozymes would cover 53.9% of the surface area of each
individual superparamagnetic bead. Thus, higher conjugation efficiencies were likely inhibited
by steric hindrances.
5.3.6

Lysozyme Activity Assay
A standard commercial lysozyme activity assay, the Enzchek Lysozyme Assay Kit (Life

Technologies) was used to determine enzyme activities using the following protocol: 2.75 µg of
Micrococcus lysodeikticus substrate was suspended in assay reaction buffer for a total volume of
50 µl and incubated for 15 minutes at 37ºC. The 50 µl of soluble substrate was added to 50 µl of
covalently immobilized Dynabeads suspended in assay reaction buffer or 50 µl of
unimmobilized lysozyme suspended in assay reaction buffer. Each 100 µl reaction was added
into a Corning Costar 3915 (Corning, NY) black fluorescent 96 well plate. Fluorescein
fluorescence released by lysozyme activity was measured per the assay kit instructions for 60
minutes using a Biotek Synergy MX monochromator set to 494 nm excitation and 518 nm
emission wavelengths. The specific activity of each lysozyme was quantified after the 60 minute
time point and normalized to the specific activity of the standard unimmobilized and untreated
lysozyme. The average concentration of the immobilized and free enzyme concentrations were
assessed for activity at 6.1±1.5 μg/ml and 22.1±5.1 μg/ml respectively.
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5.3.7

Freeze Thaw Cycles
50 µl of aliquots of site-specifically bead-immobilized lysozyme, nonspecifically bead-

immobilized lysozyme and unimmobilized lysozyme were tested for activity prior to freeze thaw
by using the lysozyme activity assay described above. After testing and washing, the lysozyme
immobilized beads and a fresh 50 µl aloquot of unimmobilized lysozyme were added to a 96
well plate and carefully sealed to prevent evaporation. The 96 well plate was stored at -80ºC for
20 minutes and then immediately placed at 25ºC for 20 minutes, a change of 105ºC. After the
completion of this cycle, the plate was returned to -80ºC for the beginning of the second cycle.
Three total freeze thaw cycles were performed. Post-freeze thaw cycles, the lysozyme activity
assay was performed to determine change in lysozyme activity after freeze thaw.
5.3.8

Urea Incubation
50 µl of aliquots of site-specifically bead-immobilized lysozyme, nonspecifically bead-

immobilized lysozyme and unimmobilized lysozyme were tested for activity prior to urea
denaturation by using the lysozyme activity assay. The assay was slightly modified by the
addition of an extra 50 µl of assay reaction buffer (total volume of 150 µl instead of 100 µl).
The lysozyme immobilized beads were then washed and stored in microcentrifuge tubes. 50 µl of
fresh unimmobilized lysozyme were also added to microcentrifuge tubes. Urea in reaction buffer
was added to both sets of lysozyme for a final concentration of 2 M urea and a final volume of
100 µl. Each reaction was then incubated in urea at 37ºC for 30 minutes. After urea incubation,
2.75 µg of Micrococcus lysodeikticus substrate solubilized in 50 µl total volume of reaction
buffer was added to each urea lysozyme set, creating a total of 150 µl for each reaction. Each
reaction was added into a 96 well plate and tested for fluorescence using the same excitation and
emission wavelengths described above.
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5.4

Results and Discussion

5.4.1

Utilizing Non-Canonical Amino Acid Incorporation to Enable the PRECISE System
The

PRECISE

system

enables

site-specific,

orientation-controlled,

covalent

immobilization of enzymes onto a chosen carrier or surface. Through the use of rationally directed,
site-specific amino acid incorporation, we have previously shown that the model reporter protein
GFP’s stability significantly improved when subjected to denaturing conditions (Smith et al.,
2013). Here, we report for the first time the covalent, site-specific immobilization of enzymes
using the PRECISE system. As described in the Material and Methods section, T4 lysozyme was
used as a model enzyme. The PRECISE-immobilized T4 lysozyme activity and stability under
denaturing conditions is directly compared to the stability of T4 lysozyme immobilized using
traditional covalent immobilization techniques. For all immobilizations, superparamagnetic beads
were employed as the enzyme carrier due to their nontoxic and biocompatible nature and facilitate
non-invasive enzyme recovery (Cao et al., 2012; Dyal et al., 2003; Lei et al., 2007; Yu et al., 2012).
The standard lysozyme, a cysteine-free T4 lysozyme variant from Addgene, was used as a template
to create six different lysozyme variants each with a single pPa non-canonical amino acid insertion
(Figure 5-1A). pPa was selected as a non-canonical amino acid enabling a click conjugation
reaction (Figure 5-1C). Variants T21pPa and K35pPa were chosen for their proximity to the
activity site with T21pPa directly next to the active site and K35pPa in the same region as the
active site.

N53pPa, K135pPa, and K162pPa were chosen as sites that had high surface

accessibility and were far from the active site region and for their presence in less structurally
important loop regions. L91pPa was selected due to prior work suggesting that it would be an
optimal, thermodynamically stable tethering site (Wei and Knotts, 2011a) (Figure 5-1A).
The nonspecific covalent enzyme immobilization technique targeting all arginines, lysines,
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and the N-terminus in the enzyme was chosen because it enabled immobilization at any one of
many sites distributed relatively equally in the enzyme, near and far from the active site, surface
accessible or buried, near or on protein loops, alpha helices, and beta sheets. Given the 26 potential
attachment residues (13 arginines, 12 lysines, and the N-terminus), approximately 1 in every 6
residues was a potential immobilization site (Figure 5-1B, 5-1D).
Auto-radiograms were performed to ensure that full-length T4 lysozyme variants
containing the non-canonical amino acid were produced when the non-canonical amino acid pPa
was added (Figure 5-1E) and that full-length T4 lysozyme was not produced when the noncanonical amino acid was omitted in the CFPS reaction (Figure 5-1F).
The post-protein purification yield for the standard T4 lysozyme ranged from 0.6 mg to
0.7 mg per 1 ml batch cell-free protein synthesis (CFPS) reaction. CFPS reactions ranging from
the 15 μl to the 1 ml scale had similar protein production yields ranging from 0.6 mg to 0.7 mg
per 1 ml batch reaction. Because the amber codon substitution system is more complex, the
yields for the lysozymes with non-canonical amino acids were lower. The post-purification yield
for T21pPa, K35pPa, and L91pPa lysozymes ranged from 0.25 mg to 0.3 mg per 1 ml batch
reaction. For N53, K135, and K162, protein yields were typically less than one-third as
productive, ranging from 0.04 mg to 0.1 mg per 1 ml batch reaction.
5.4.2

Activity of the T4 Lysozyme Variants
The insertion of the non-canonical amino acid, pPa, had divergent effects on the activity of

each lysozyme variant dependent upon the location of the mutation at each of the six rationally
engineered sites (Figure 5-2). The lysozyme variants immediately next to the active site (T21pPa)
and near the active site (K35pPa) suffered the most dramatic decrease in activity, with the
lysozyme variant T21pPa retaining less than ten percent of the activity of the standard lysozyme.
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Given the proximity of the non-canonical amino acid to the active site, these effects were expected
and consistent with previous research that report the effect of amino acid mutations near the active
site (Greenwald et al., 1999). The three variants that were chosen for their surface accessibility
and distance from the active site, N53pPa, K135pPa, and K162pPa, maintained much higher
activity, ranging from 70 percent to 85 percent of the activity of the standard lysozyme. The final
variant, L91pPa, showed activity in solution that placed it in the middle of the range between the
three variants N53pPa, K135pPa, and K162pPa that were further from the active site. These
differences in enzyme activity post-unnatural amino acid insertion demonstrate the importance of
careful selection of the insertion site.
This data supports avoiding the active site region and choosing surface exposed and
flexible areas for non-canonical amino acid incorporation. However, avoiding active sites and
choosing surface exposed sites for non-canonical amino acid incorporation becomes difficult in
instances where the protein of interest’s structure remains unsolved. Given that the Protein Data
Bank’s approximately 92,000 solved structures remains a small fraction of all known protein
sequences, the continued acquisition of data on the effect of non-canonical amino acid
incorporation sites on activity and structure as well as the development of better experimentally
validated simulation software is needed to realize the full potential of non-canonical amino acid
applications.
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Figure 5-2: T4 Lysozyme Specific Activity. A. The activity of each lysozyme measured for 60
minutes at 37ºC. The activity shown is normalized for enzyme concentration and thus is a
measure of the specific activity of each lysozyme. B. The specific activity of each lysozyme
normalized to the specific activity of the standard lysozyme. (Wu et al., 2015).
5.4.3

Effect of Lysozyme Immobilization on Lysozyme Activity
Due to the consequences of steric effects and steric hindrance in particular, the orientation

of the immobilized enzyme can have a significant effect on enzyme activity. To test these effects,
lysozyme variants were covalently immobilized on superparamagnetic beads at the non-canonical
amino acid site using PRECISE technology (Smith et al., 2013) (Figure 5-1C). For scaled up
production and immobilization the lysozyme variants T21pPa, K35pPa, and L91pPa were
specifically chosen because of high protein expression yields in the E. coli-based cell-free protein
synthesis system and their representation of a location at the active site, a location in the proximity
of the active site, and a location away from the active site which is also the best location predicted
by simulation (Wei and Knotts, 2011a). The specific activity of each immobilized variant was
measured and compared to covalent nonspecifically immobilized standard lysozyme (Figure 5-3).
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The activity of standard lysozyme prior to immobilization was used as a conservative control for
comparison as it had significantly higher activity than any other lysozyme variant prior to
immobilization.

Figure 5-3: T4 Lysozyme Specific Activity Post-Immobilization. A. The specific activity of
each lysozyme variant measured for 60 minutes at 37ºC. The activity shown is normalized for
enzyme concentration and thus is a measure of the specific activity of each lysozyme. The (I)
symbol is added to signify each type of lysozyme that is immobilized. B. The specific activity
of each immobilized lysozyme normalized to the unimmobilized standard lysozyme. C.
Percentage change in lysozyme activity post-immobilization. (Wu et al., 2015).
The distinct changes in enzyme activity for each lysozyme variant post-immobilization
strongly suggest that immobilization orientation has a significant effect on enzyme activity (Figure
5-3). As initially predicted, the immobilization next to active site (T21pPa) resulted in a large
decrease in specific activity (44% drop). Nonspecifically immobilizing the standard lysozyme
also resulted in a similar, large decrease in specific activity in percentage terms (46% drop),
although it maintained higher activity in absolute terms than the T21pPa immobilized variant. In
contrast, the remaining two site-specifically immobilized variants, L91pPa and K35pPa, exhibited
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much smaller drops in specific activity (19% and 24% drop respectively). Consequently, L91pPa
had the highest absolute activity of all the immobilized lysozyme types post-immobilization
(Figure 5-3). Thus, these results suggest that the advantages of
immobilization orientation control in the demonstrated system can outweigh the costs in enzyme
activity due to the incorporation of the non-canonical amino acid.
5.4.4 Effect of Lysozyme Immobilization Orientation on Lysozyme Activity Retention PostFreeze Thaw Cycling
Following immobilization, we evaluated the effect of immobilization orientation on
activity after subjecting the enzymes to denaturing conditions. For this evaluation immobilized
K35pPa, L91pPa and standard lysozyme variants were used. The immobilized T21pPa lysozyme
variant was not used due to its very low activity close to background. The immobilized K35pPa
variant was included in the stability experiments as it had higher activity than the T21pPa variant
and enabled us to examine the effect of near-active site immobilization on post-immobilization
lysozyme activity. Given that enzymes are commonly frozen for storage and later thawed for both
industrial and research purposes, with the freezing and thawing process producing significant
changes in buffer and salt concentrations, which can cause denaturation in the absence of a
cryoprotectant, freeze thaw cycles were utilized to assess the role that immobilization orientation
plays in promoting or weakening enzyme stability (Pikal-Cleland et al., 2000).
After subjecting the lysozyme variants to three freeze thaw cycles of -80ºC to 25ºC in the
absence of a cryoprotectant, the standard lysozyme, K35pPa, and L91pPa variants all suffered a
significant decrease in activity, with all enzymes retaining only 20 to 30 percent of their pre-freeze
thaw activity (Figure 5-4).
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Figure 5-4: Post-Freeze Thaw Stability. Each lysozyme was subjected to three freeze thaw
cycles. Each cycle consisted of 20 minutes at 80°C followed by 20 minutes at 25°C. A. Percent
of lysozyme activity retained post-freeze thaw. B. Normalized lysozyme activity standardized
to the untreated and unimmobilized standard lysozyme. (Wu et al., 2015).
In contrast, all of the immobilized enzymes, specific and non-specific retained significantly
greater activity, with far greater activity retention seen with the K35pPa and L91pPa (~70-80%
retention) site-specifically attached lysozyme variants compared to nonspecifically immobilized
standard lysozyme (42% retention). In absolute terms, immobilized L91pPa was 141% more active
than the unimmobilized standard lysozyme post-freeze thaw and 50% more active than the
nonspecifically immobilized standard lysozyme (Figure 5-4).

Thus, although traditional

nonspecific enzyme immobilization affords increases in enzyme stability, such stability
improvements can be significantly increased through an attachment that enables enzyme
immobilization orientation control.
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5.4.5 Effect of Lysozyme Immobilization Orientation on Lysozyme Activity Retention PostUrea Incubation
The mechanism of urea denaturation is believed to be caused by direct urea-protein
interactions and/or by perturbation of solvation environment around the protein by urea, increasing
solvation of hydrophobic groups (Hua et al., 2008). Urea denaturation thus acts in a very different
denaturation process than freeze thaw cycles, making it another useful tool for evaluating stability.
Similar to the data obtained after freeze thaw denaturation, site-specifically immobilized
K35pPa and L91pPa lysozyme variants retained a higher percentage of activity than the
nonspecifically immobilized standard lysozyme and all unimmobilized lysozymes.

All

unimmobilized lysozymes lost the majority of their activity retaining approximately 20 to 40
percent of their pre-urea activity (Figure 5-5). Similar to the freeze thaw denaturation, both of the
site-specifically immobilized lysozyme variants retained more than 70% of their pre-urea
incubation activity while the nonspecifically immobilized standard lysozyme lost 67% of its preurea activity. On an absolute activity scale, site-specifically immobilized L91pPa lysozyme was
more than twice as active as unimmobilized standard lysozyme after urea treatment and was 73%
more active than the nonspecifically immobilized standard lysozyme (Figure 5-5).
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Figure 5-4: Post-Urea Incubation Stability. Each lysozyme was incubated in 2M urea at 37°C
for 30 minutes and then assayed for activity. A. Percent of lysozyme activity retained post-urea
incubation. B. Normalized lysozyme activity standardized to the untreated and unimmobilized
standard lysozyme. (Wu et al., 2015).
5.5

Conclusion
Here we employ our recently developed PRECISE system to demonstrate for the first time

site-specific covalent immobilization of enzymes at residues throughout the enzyme. Different
from prior immobilization techniques, as demonstrated here, the PRECISE system is an entirely
covalent immobilization that requires only a single substitution or insertion to facilitate
immobilization orientation control (Ewers et al., 2005; Kalia et al., 2007; Lim et al., 2014; Seo et
al., 2011; Smith et al., 2005). We have demonstrated that by controlling the immobilization
orientation, greater enzyme stability can be realized than nonspecific covalent immobilization,
even by 50% and 73%.

Improved stability is especially important for developing enzyme

biocatalysts capable of long-term reuse and thus enabling economically competitive biocatalyst
use in lower margin chemical applications.

As a potential industrially relevant carrier,
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superparamagnetic beads were employed as the immobilized enzyme carriers. These beads
provide facile recovery and reuse of the enzymes as was demonstrated during the stability assays.
We have also provided preliminary data suggesting that current simulation capabilities may
be useful in selecting a good location for enzyme immobilization, with the simulation-predicted
L91 site being the most stable location for enzyme immobilization under two different denaturing
conditions. Overall, the PRECISE system enables a truly covalent attachment of the enzyme at
potential any accessible residue and is an attractive technology to determine the optimal orientation
for enzyme immobilization for biocatalysis applications.

6.

Conclusions and Future Work
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6.1

Thermodynamic Stability of Immobilized Enzymes: Explanations for Increased Stability
Our experimental findings on lysozyme stability support prior molecular modeling

predictions that enzyme immobilization at residue 91 would increase stability over
unimmobilized enzyme and enzyme immobilized at other sites (Wei and Knotts, 2011b).
However, our studies also supported prior research that demonstrated that enzyme
immobilization generally increases enzyme stability (Friedel et al., 2007). Dill et al have
theorized that the entropic cost of folding on a surface is less than or equal to the cost of folding
in solution in all instances, thus increasing the thermodynamic stability of enzymes when
immobilized on a surface (Dill and Alonso, 1988; Zhou and Dill, 2001). Other molecular
modelers have tested this hypothesis and found strong supportive evidence of this theory, but
noted that the strength of the stability improvements rely on the specific immobilization site
(Knotts Iv et al., 2008). Based on the additional stability improvements that our site-specific
immobilization technique demonstrated over the traditional, nonspecific covalent techniques, we
find support for this hypothesis – that the decrease in entropic cost for folding stabilizes
immobilized enzymes, but that careful site selection is crucial for maximizing stability benefits.
6.2

Future Work
Given the importance of site selection for maximizing enzyme stability benefits and due

to the location-specific impact of non-canonical amino acid incorporation, better techniques for
evaluating the best locations for non-canonical amino acid incorporation must be developed. For
proteins and enzymes that have a solved crystal structure, the choice of the most advantageous
incorporation sites is simplified. The traditional rules of selecting an external, non-structurally
significant lengthy loop region far from the active site or the closest approximating site might
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provide a good initial region to begin looking for a viable immobilization site. In the alternative,
molecular modeling may also provide an effective strategy for discovering the most stable
immobilization site.
However, for the vast number of proteins and enzymes that do not have a solved crystal
structure or close homology to a solved structure, molecular modeling may be quite difficult. To
provide an example, the I-Tasser homology/folding-based protein structural prediction program
by the Zhang Research Group at Michigan and the Quark ab initio protein structural prediction
program by the same research group currently provide the most accurate protein structural
prediction software as assessed by the Critical Assessment of protein Structural Prediction
(CASP), the foremost competition for protein structural prediction (Roy et al., 2010; Xu et al.,
2011). Despite being the most advanced and accurate protein structural prediction software, both

Figure 6-1: Protein structural prediction models. Models produced from I-Tasser and Quark
when given the amino acid sequence of the T4 Lysozyme (PDB ID: 7LZM). The correct
structure is colored in blue, the predicted structure is colored in gold.

83

software programs suffer from significant prediction inaccuracies where a protein lacks greater
than 10% homology with a protein whose crystal structure has been previously solved (Figure 61).
We are currently working on a high-throughput system for testing large numbers of noncanonical amino acid incorporation sites concurrently using linear expression templates produced
in the cell-free protein synthesis system that enable same-day design, protein testing, and protein
production that will hopefully, work to address the difficulty of finding the most advantageous
incorporation sites.
In conclusion, using the technologies of cell-free synthetic biology, non-canonical amino
acids, and click conjugation, we have demonstrated a powerful new technology that enables
significant activity and stability benefits in proteins and enzymes, a better understanding of
enzyme-surface interactions, and that may help to simplify protein production of proteins with
unique new qualities.
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Figure 7-1: Crystal Structure of sfGFP-related Protein. The potential implications of the residue
location for unnatural amino acid incorporation were investigated using the known crystal
structure of a superfolder green fluorescent protein variant closely related to the pPaGFP (pdbID
2B3P).(Pedelacq et al., 2006) In the Fig. S1, the beta-barrel (dark green) is approximated as a
cylinder with the loop of interest (pink) extending from the main body. The pink loop contains
the location for the unnatural amino acid incorporation (black). (Smith et al., 2013).
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Figure 7-2: Aminoacyl-tRNA Synthetase Optimization. Cell-free protein synthesis allows for
direct access to the synthesis environment, enabling optimization and maximization of synthesis
cofactors. To maximize the unnatural amino acid incorporation, the effect of different
concentrations of aminoacyl-tRNA synthetase and magnesium glutamate on the production of
active pPaGFP was assessed. (Smith et al., 2013).
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Figure 7-3: Scintillation and Fluorescence Data for Washes after pPaGFP Immobilization. To
ensure that the proteins were not remaining in solution or non-specifically binding to the
magnetic beads, the beads were washed 3 times using a PBS-Tween buffer. Each wash consisted
of isolating the magnetic beads, removing the supernatant, and resuspending the beads in 100 μL
PBS-Tween buffer. The final suspension (labeled “Beads”) was in 100 μL PBS and was vortexed
directly prior to analysis for a uniform suspension of beads. Displayed above are the results from
liquid scintillation and fluorescence analysis of supernantant from washes 2 and 3, along with the
final suspension containing beads. During the washing process, the unclicked pPaGFP was
removed to background or statistically insignificant levels. For the control reactions containing
no copper, the resuspended beads contained no or insignificant levels of pPaGFP. The prewash
and wash 1 results were removed to provide appropriate scaling. Error bars = standard deviation,
n=2. (Smith et al., 2013).
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Figure 7-4: Freeze-thaw Activity for Free pPaGFP in Copper-containing Solutions. Free
pPaGFP was incubated under the same conditions as bead-immobilized pPaGFP and then was
left in its respective reaction solution. The unbound pPaGFP was subjected to multiple freezethaw cycles (squares) or incubated at 4 oC (diamonds) and assayed for activity. Each freeze-thaw
cycle consisted of an incubation for 20 min at -80 oC followed by a 20 min incubation at room
temperature. Samples left unfrozen were maintained at 4 oC for 40 min between assays. The
results suggest that incubation with copper plays little role in terms of stability during freezethaw cycles. Error bars = standard deviation, n=2. (Smith et al., 2013).
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